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ABSTRACT 
The human pathogen Campylobacter jejuni is naturally competent for 
transformation with its own DNA. In this thesis work, we investigated key gene 
products of the transformation apparatus as well as the mechanism by which C. 
jejuni selects DNA for uptake and recombination. We demonstrate that two 
NTPases, CtsP and CtsE, are required for transformation. Their localization to 
the membrane is through a mechanism not generally observed with other 
competence ATPases.  Further, CtsP interacts with another competence protein, 
CtsX, a single-pass transmembrane protein lacking significant homology to other 
proteins.  Also investigated was the mechanism of DNA selection in C. jejuni. 
This bacterium is very selective in the DNA it uses during transformation, only 
using self or DNA derived from closely related strains. We demonstrate that this 
selection is based on adenine-methylation within a specific sequence motif, 
RAATTY.  This site is broadly conserved in Campylobacter species and is over-
represented in the C. jejuni genome. Methylation at RAATTY is conferred by 
CtsM, an orphan DNA methyltransferase also highly conserved in 
Campylobacter.   CtsM is dispensable for transformation, but genomic DNA from 
a ctsM mutant serves as a transformation substrate with efficiency several orders 
of magnitude below DNA from a ctsM+ strain.  A single methylated site is 
sufficient to confer wild type transformability to otherwise untransformable DNA. 
We also demonstrate that DNA lacking RAATTY methylation is transported 
  xiv 
inside the cell, implying that discrimination of methylated versus unmethylated 
DNA does not occur on the outer membrane. Finally, this work provides a 
potentially powerful tool to carry out rapid genome editing of C. jejuni, requiring 
only that an incoming homologous DNA fragment be RATTY-methylated for 
uptake and recombination. This is the first example of a methylation dependent 
mechanism of DNA selection during transformation. 
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CHAPTER I 
 
INTRODUCTION 
 
1.1 Introduction 
Natural transformation, or competence, is the process by which bacteria 
encode a dedicated transport system to bring DNA from their environment into 
the cell and recombine it into their genome.  This process uses protein machinery 
conserved in systems of protein secretion and pilus assembly; this machinery is 
similar in most bacteria that are naturally competent.  Notwithstanding this 
similarity, competent bacteria have distinct mechanisms to regulate the 
recognition and uptake process, enabling them to optimize DNA uptake by 
enhancing the likelihood of taking up DNA from closely related bacteria.  These 
mechanisms include activating competence under circumstances where the 
bacteria are likely to encounter DNA, either through quorum sensing or by 
promoting active DNA release.   
DNA methyltransferases (MTases), and the modifications they provide, 
are even more widespread than natural transformation.  These enzymes often 
work in concert with restriction endonucleases in restriction modification (RM) 
systems. These systems protect the bacteria from incoming DNA.  MTases not 
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part of a restriction modification system regulate gene expression through 
epigenetic DNA modification.   
C. jejuni is a naturally competent bacterium that causes bacterial 
gastroenteritis. Competence in C. jejuni appears to be a constitutive trait, 
although the efficiency can be affected by different conditions tested in the 
laboratory [1, 2]. C. jejuni is also competent during in vivo conditions such as in 
the chicken intestinal tracts and within biofilms [3, 4].   
The predominant machinery for DNA uptake is encoded by the cts system, 
which includes gene products similar to those used in both secretion and pilus 
assembly systems in a range of bacteria [5].  At least in the laboratory, C. jejuni 
can efficiently select its own DNA and discriminate against DNA from other 
species; the mechanism by which this occurs has not been determined.  The C. 
jejuni genome encodes a number of RM systems and orphan MTases, which 
may contribute in part to its ability to discriminate DNA.  
1.2 Campylobacter jejuni 
Campylobacter species are Gram-negative, microaerophilic, spiral-
shaped, motile bacteria [6].  They can be found in the gastrointestinal tract of 
many animals and avian species where they are often considered commensal 
bacteria, particularly in avians. They have a small genome, approximately 1.6-1.7 
Mbp in size [7-9].  They have flagella at each pole of the cell and are small in size 
ranging from 0.5-5 µm long and 0.2-0.8 µm wide.  Unlike many other bacteria, 
they primarily rely on amino acids for energy.  As they are colonizers of both 
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mammals and birds, they grow equally well at 37°C and 42°C, the respective 
body temperatures of those animals.  
1.2.1 Campylobacteriosis 
Campylobacter spp. are among the major cause of acute bacterial 
gastroenteritis worldwide. Most of these cases are from either C. jejuni or C. coli. 
In 2014, 88% of the speciated isolates causing campylobacteriosis in the United 
States were C. jejuni and 9% were C. coli [10].  The infectious dose is very small, 
ingenstion of fewer than 500 bacteria are required to cause illness [11]. 
Transmission generally occurs from contaminated food or water sources.  A 
major source of infection by humans is poultry; in 2011, Campylobacter was 
found on 47% of raw chicken samples in grocery stores that were tested through 
the National Antimicrobial Resistance Monitoring System (NARMS) [10]. In 
humans, C. jejuni will colonize the intestinal epithelium causing a range of 
symptoms from mild, watery diarrhea to severe, bloody diarrhea.  C. jejuni is 
estimated to infect over 1.3 million individuals annually in the United States [11]. 
Infection is also associated with the development of Guillain-Barré syndrome 
(GBS), a severe immune mediated neurological disease that results in paralysis 
[11]. According to the CDC, as many of 40% of the GBS cases in the country 
may be triggered by campylobacteriosis [11].    
C. jejuni has also been declared to be an urgent threat by the CDC, due to 
the rise of antibiotic resistance.   According to a 2013 report, there are 310,000 
drug-resistant Campylobacter infections per year [12].  Resistance to 
ciprofloxacin, one of the main drugs for treating infections, has risen to almost 
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25% of cases [12].  There is also documented resistance to azithromycin, one of 
the other main drugs for treating Campylobacter infections [12].  
1.2.2 Genetic diversity 
Bacterial species can vary widely in the extent of genome conservation.  
Borrelia burgdorferi exists mainly as a clonal population with little genetic 
diversity between sequenced strains.  In contrast, Helicobacter pylori has a non-
clonal structure with such extensive diversity that it is common to find a high 
degree of intra-strain sequence variation even within a single gene [13-16].  As 
Campylobacter spp. are closely related to Helicobacter, it is not surprising that it 
has extensive genetic diversity as well. This was first recognized when multilocus 
sequence typing (MLST) was applied to Campylobacter isolates [17-19].  One 
such study looked at seven housekeeping genes from thirty-three C. jejuni 
isolates.  Of the 33 isolates tested, only two had identical sequences for all seven 
genes, and a homoplasy ratio between 0.36 and 0.48 was determined [17].  The 
homoplasy test indicates the frequency of recombination within a population, with 
values ranging from 0 to 1.  Zero indicates clonal descent and one indicates non-
clonal descent where the population has been freely recombining [15].   Another 
study looking at more strains concluded that intra-and interspecies recombination 
frequently occurs in Campylobacter [19]. The amount of genetic diversity 
observed in C. jejuni is less that of Streptococcus pneumoniae, but similar to that 
of Neisseria meningitides.   Whole genome sequencing of Campylobacter strains 
confirms these earlier studies postulating a high degree of genetic exchange [20].  
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The two major mechanisms for generating diversity within bacterial 
species are i) through replication errors or DNA damage and ii) through 
horizontal gene transfer (HGT).  Accumulation of mutations leads to a slow and 
steady diversification over time. HGT results in transfer of large pieces of DNA 
and therefore quick, significant change.  The three major mechanisms of HGT 
are conjugation, transduction, and natural transformation.  Conjugation is the 
contact-dependent transfer of DNA between two strains. Transduction is the 
transfer of DNA between bacteria by bacteriophage. Natural transformation is the 
acquisition of DNA from the environment by a bacterium through a dedicated 
protein transport system. C. jejuni undergoes HGT from all of these processes, 
contributing to its genetic diversity.   
Some of the genome diversity can also be attributed to its phase variation 
system.  Phase variation occurs due to alteration within polyG:C tracts.  Changes 
in the number of nucleotides within a region containing a polyG:C tract, most 
likely due to slipped-strand mispairing during chromosome replication, shifts the 
gene in and out of frame and thus cause phenotypic variation [21]. Production of 
lipo-oligosaccharide, a key molecule underlying GBS, is regulated by phase 
variation [22-24]. At least eight other genes are thought to be phase variable as 
well, including a MTase with potential regulatory roles that will be discussed in 
Section 1.5.5 [21, 25, 26] 
1.3 Natural transformation 
Natural transformation has been described in over 65 species [27]. While many 
species can be artificially induced to take up DNA by manipulating their 
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membranes, naturally competent bacteria encode dedicated machinery used to 
transport DNA from the extracellular space into the cytosol where it can 
recombine into the genome.  Generally this machinery resembles that of Type II 
secretion systems (T2SS) or Type IV pilus biogenesis systems (Tfp) [28]. H. 
pylori is a major exemption, as it uses a Type IV secretion system (T4SS) 
typically associated with conjugation (T4SS) [29, 30].  C. jejuni carries a plasmid, 
pVir, that encodes a T4SS that has been implicated in competence, but it is not 
the major contributor to this trait as the Cts system noted above predominates for 
competence [5, 31]. Deletion of transformation genes encoded on pVir decreases 
transformation efficiency but the decrease is negligible as compared to deletion 
of cts genes where few to no transformants are ever detected.  
1.3.1 Proposed benefits to natural transformation 
There are three principal hypotheses for fitness advantages conferred by  
a dedicated DNA uptake system; they are not mutually exclusive.  These are 1) 
DNA for food, 2) DNA for repair, and 3) DNA for evolution.  These have been 
extensively reviewed but brief summaries of each, and the major evidence 
supporting them, are provided below [32, 33].  
DNA for food 
The idea of DNA as a source of nutrients proposes that competence exists 
primarily to transport a source of nucleotides into the bacterium instead of 
synthesizing them de novo [34, 35].  For this hypothesis, recombination that 
occurs (DNA for repair or evolution) is a bonus of acquiring DNA as a metabolic 
substrate.  The main arguments underlying this hypothesis are 1) using DNA for 
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food nets an immediate gain whereas any benefits from recombination may only 
be selected for long term. 2) Nutritional stress can induce competence in some 
species, including Haemophilus influenzae and Bacillus subtilis, though this is not 
true of all bacteria.  In fact, some bacteria, such as Streptococcus pneumoniae, 
induce competence in rich media at low cell density, conditions in which there is 
presumably no nutritional stress [35-38]. 3) DNA damage does not induce 
competence in all bacteria, notably H. influenzae and B. subtilis. If competence 
were used for repair, DNA damage would be predicted to induce competence. 4) 
While homologous DNA can recombine, non-homologous DNA may be degraded 
and used as a nutrient source.  5) DNA that is in the extracellular environment 
might be damaged and therefore would not be a suitable substrate for 
recombinational repair or evolution [39, 40]. However, many bacteria have 
evolved mechanisms to co-regulate competence with bacterial killing or DNA 
donation so that the DNA they acquire would be in good condition [41, 42]. This 
has been demonstrated in S. pneumoniae and Neisseria gonorrhoeae and will be 
discussed in more detail later.  Work in E. coli and Vibrio cholerae support this 
hypothesis as each of these bacteria can grow on DNA as a sole carbon source 
so DNA can be used for nutritional purposes [43-46].  However, it is unclear if the 
mechanism for transport of the DNA is identical to that used in competence.   
A number of findings do not support a hypothesis that DNA is a food 
source. For example, in addition to its competence system, B. subtilis has an 
extracellular nuclease and uptake systems for nucleotides and nucleosides.  It is 
unclear why a separate DNA uptake system would be maintained if the cell were 
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able to take in nucleotides directly  [28].  As will be described in detail below, 
both V. cholerae and C. jejuni possess extracellular DNases whose activity 
inhibits competence [47-50]. Furthermore, the advantage of using a complex, 
multiprotein competence machinery that requires ATP cleavage to bring in DNA, 
as opposed to simply synthesizing nucleotides, is not clear [5, 28, 51, 52].  DNA 
uptake motors have been described as some of the strongest linear motors 
characterized to date and are energetically costly to the cell [51, 53-55].      
DNA for repair 
The major argument that DNA is taken up primarily to repair errors in the 
chromosome is that many species of competent bacteria are either biased 
towards or selective for DNA from closely related individuals.  This will be 
discussed later, but briefly these mechanisms include using DNA uptake 
sequences as in Neisseria and Haemophilus, using restriction modification 
systems as in Helicobacter and Pseudamonas, using a competence pheromone 
as in V. cholerae and S. pnuemoniae, or using CRISPR/Cas as in N. 
gonorrhoeae. By selecting the DNA brought into the cell during competence, the 
bacteria can maintain genetic integrity.  It should be noted that studies in H. pylori 
or Legionella pneumophila have provided evidence against this hypothesis.  
When their DNA uptake systems were inactivated, there was no change in their 
susceptibility to DNA damage inducing agents [56, 57].  Also, as noted above, 
neither B. subtilis nor H. influenzae induce competence in response to DNA 
damage. However, S. pneumoniae does induce competence upon DNA damage.  
Normally the protease HtrA degrades CSP. When misfolded proteins accumulate 
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because of stress of genomic errors, they become the preferred substrate for 
HtrA which allows CSP to accumulate and induces competence.[58].  
DNA for evolution 
The third hypothesis for natural transformation is that the ability to import DNA 
and recombine it onto the chromosome might allow for rapid evolution in times 
when diversity is be beneficial, such as during high population densities, nutrient 
stress or starvation, or DNA damage.  As all of these are known to induce 
transformation in at least some bacteria, there is a great deal of evidence for this 
hypothesis. However, directly testing this hypothesis is challenging [59].  Most 
experiments have a bias towards seeing benefits from acquiring DNA.  There 
have been a few studies, including one with long-term in vitro passage of H. 
pylori where competent bacteria increased their fitness faster than their non-
competent counterparts [60].  Furthermore, because competence is a complex 
process that is often co-regulated with other processes such as fratricide or 
bacteriocin production, Type VI secretion, or quorum sensing, unlinking the 
evolutionary benefits that derive directly from competence as opposed to these 
other traits is challenging [42, 61-66].  
As mentioned in the introduction to this section, none of these hypotheses 
are mutually exclusive.  Considering the diversity in competent bacteria, in the 
regulation of the systems, and in the makeup of the systems themselves, it 
seems likely that there is no single hypothesis that completely describes the 
fitness advantage conferred by the ability to take up intact DNA. It is also 
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possible that different forces drove the development of competence and thus 
different hypotheses hold for different bacteria.  
1.3.2 Regulation of transformation 
The strategies for regulation of transformation are diverse and vary in 
different bacteria.  Some bacteria, such as H. pylori and N. gonorrhoeae, are 
constitutively competent [56, 67].  Other bacteria, such as S. pneumoniae and B. 
subtilis, tightly regulate their competence machinery such that they are only 
competent for small windows of time.  In other cases, such as V. cholerae, 
competence is co-regulated with other bacterial processes such as quorum 
sensing and type VI secretion.  As the regulation of competence has been 
extensively reviewed, I will only go into brief detail for S. pneumoniae and V. 
cholerae [28, 68-71].  
In V. cholerae, competence is regulated by TfoX, the master competence 
regulator [72].  This is a homolog of the Sxy regulator in H. influenzae [72]. The 
TfoX regulon has not been completely deciphered, but we know that it regulates 
the biosynthesis of the structural genes in the Tfp machinery used by V. cholerae 
to bring DNA into the cell [73-75]. Some of these genes also require input from 
HapR, the master regulator of quorum sensing (QS) as well as QstR (QS-
dependent and TfoX-dependent regulator) [48, 76, 77]. TfoX is induced by 
growth on chitin and HapR is induced by high cell densities and accumulation of 
CAI-1, the species-specific autoinducer of competence [48, 72].  Both TfoX and 
HapR activate QstR which goes on to activate a subset of genes involved in 
transporting the DNA from the periplasm to the cytosol (comEC and comEA) as 
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well as the T6SS operon.  [48, 76] [63].  QS also regulates production of an 
eDNase, Dns, that is expressed at low cell densities and prevents transformation 
[47]. Expression of dns is repressed by HapR [47]. Repression of dns allows the 
competence machinery to gain access to intact DNA, facilitating DNA uptake. 
This extensive co-regulation of competence, QS, and T6SS results in 
competence expression during high cell densities by cells actively producing 
machinery to kill other bacteria and release DNA. 
In S. pneumoniae, competence is induced by environmental cues such as 
antibiotic treatment or  by early exponential growth, both which require the  
competence pheromone, CSP [37, 78, 79]. CSP is produced as peptide inside 
the cell and transported out through the ABC transporter ComAB [80, 81].  
ComAB also processes CSP to its active form [81, 82].  Extracellular CSP is 
recognized by the two component system ComDE. ComE, the response-
regulator, is phosphorylated by ComD, the histidine kinase, and then activates 
the early competence genes as well as the alternative sigma factor, comX [80, 
83].  ComX activates the rest of the genes including the structural genes required 
for DNA transport. These transcription factors also activate fratricide effectors 
and bacteriocins, along with their respective immunity proteins [42, 66, 78, 84-
86].  As in V. cholerae, co-regulation of these systems results in the activation of 
competence in an environment where there is likely to be DNA available for 
uptake.  
1.3.3 Transformation Machinery 
 12 
 
Generally, the machinery used in transformation resembles T2SS and Tfp 
systems, with the major exception being H. pylori, which uses a T4SS to 
transport DNA. This is depicted in Figure 1 [29, 51, 87-90].  Despite differences 
between Gram-positive and Gram-negative bacteria, there are many conserved 
features between the systems.   These mechanisms have best been described in 
B. subtilis for Gram-positive organisms and in N. gonorrhoeae and V. cholerae 
for Gram-negative organisms and I will focus on those in this discussion [87, 89-
91].  I will also include H. pylori as although it has a different system, in some 
aspects it functions similarly [88]. Information from bacteria such as S. 
pneumoniae will be included to fill in gaps in knowledge. 
The goal of transformation is to transport DNA into the cytosol where it 
can recombine with the chromosome.  Because the cell wall and membranes 
differ between Gram-positive and Gram-negative bacteria, each class of bacteria 
must to overcome different challenges to transport DNA into the cytosol.  For 
Gram-positive bacteria, DNA has to be transported through a thick cell wall and 
then through one membrane into the cytosol. Gram-negative bacteria have two 
membranes through which they must transport DNA. Therefore in these bacteria, 
transport into the periplasm is the first step and this renders the incoming DNA 
resistant to eDNases [87].  In order to become eDNase resistant in Gram-positive 
bacteria, the DNA must be transported into the cytosol [87].  
For both types of bacteria, it appears dsDNA is bound on the outside of 
the cell with varying degrees of specificity depending on the requirement for an 
uptake sequence.  Once the DNA is bound, the transformation machinery can 
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transport the DNA into either the cytosol in the case of Gram-positive bacteria or 
into the periplasm in Gram-negative bacteria [87]. In Gram-negative bacteria, 
dsDNA is transported into the periplasm where it is bound by proteins that 
facilitate its transport to another pore through which it is then translocated into 
the cytosol. During the translocation process, one strand is degraded.  
Step one: DNA binding and transport towards the cytosol.  
As briefly described above, the first step in transformation is binding of the 
DNA to the cell surface.  In B. subtilis, a pseudopilus is made composed of the 
ComG proteins (ComGC, GD, GE, GG) [92].  In intact cells, the pseudopilus is 
required for the interaction of the transforming DNA with the DNA binding protein 
ComEA which localizes at the cytoplasmic membrane [92].  When protoplasts 
(cells lacking peptidoglycan) are made, the pseudopilus is not required for the 
ComEA-transforming DNA interaction [92].  This indicates that the pseudopilus 
functions to penetrate the peptidoglycan and create a pore for the DNA to enter.  
It is unclear if the DNA directly interacts with the pilus, though it seems unlikely 
as the ComG proteins do not bind DNA [92].   However, in S, pneumoniae the 
competence pilus has been shown to directly bind to DNA.  [93]. 
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Fig 1.1. Model transformation systems. The transformation systems of B. subtilis, N. 
gonorrhoeae, H. pylori and C. jejuni are modeled above. Homologous or conserved 
proteins are color coordinated.  Green denotes pilins or pseudopilins. Yellow denotes 
ComE-like DNA binding proteins. Pink denotes ComA or ComEC DNA transporters. 
Orange denotes either PriA or ComFA.  Light orange denotes protein is found in the 
genome of C. jejuni but has not yet been implicated in competence.  Purple denotes 
ATPases that power the pilus and transformation. ssDNA binding proteins are denoted 
in brown. Proteins that are not conserved are denoted in navy blue.  
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In Gram-negative bacteria, the DNA has to be transported sequentially 
through both membranes before it enters the cytosol.  In Neisseria, the secretin 
PilQ in the outer membrane can bind to both dsDNA and ssDNA in a sequence-
independent manner [94].  The minor pilin, ComP, binds specifically to the DNA 
uptake sequence (DUS) and is thought to be responsible for the import of DUS-
containing DNA [95]. In Neisseria, functional type IV pili are required for 
transformation; this is not true of all Gram-negative bacteria [96].  Functional type 
IV pili require two ATPases, PilF and PilT for assembly and disassembly of the 
pilus respectively.   The pore of PilQ is at least 6.5 nm at its narrowest point 
which is sufficiently large to allow for pili to translocate through [97].  The pili 
lumen are rather hydrophobic and measure about 1.2 nm in diameter [96].  This 
is not sufficiently large to allow dsDNA, approximately 2.4 nm, to pass through.  
These data lead to two main hypotheses for how the DNA enters the periplasm.  
The first is it binds directly to the pilus and as the pilus is disassembled by the 
action of PilT, the DNA is pulled into the periplasm.  The second hypothesis is 
that retraction of the pilus opens a gap in the secretin and that gap is filled by 
DNA.  Once the DNA is brought into the periplasm, it is bound by ComE, a 
homolog of ComEA in B. subtilis [88]. As a corollary to the second hypothesis 
proposed above, it is hypothesized that the binding of ComE to the incoming 
DNA might work as a ratchet mechanism that facilitates movement of the DNA 
across the membrane, though currently there are no experimental data to 
support that hypothesis [88].  
Step two: transport across the cytoplasmic membrane 
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In both Gram-positive and Gram-negative bacteria, before the DNA is 
transported into the cytosol, it is double-stranded.  At some point in the transport 
process, the DNA is processed into ssDNA; this happens in a strand-
independent manner [98, 99].  The mechanism for this degradation has yet to be 
elucidated. Transport across the cytoplasmic membrane relies on the 
homologous membrane proteins ComEC and ComA of B. subtilis and N. 
gonorrhoeae respectively [100].  These proteins are thought to function as an 
oligomer with multiple transmembrane passes. The transport process is highly 
specific for DNA as DNA that has been modified such as covalently labelled 
fluorescent DNA is unable to be transported across the cytoplasmic membrane in 
both H. pylori and B. subtilis [101]. The motor that powers this process is not 
clear, though a strong pulling force has been recorded when uptake was 
measured with laser tweezers in B. subtilis [54]. This indicates that there is some 
molecular motor involved. ComFA, a DEAD-box helicase, is important for 
translocating DNA in B. subtilis [102]. However, genes encoding for ComFA 
homologs are not found in the genomes of many competent bacteria indicating 
that this helicase is not a universal component of transformation systems. PriA, a 
related helicase, is found ubiquitously in bacteria because it is involved in the 
restart of chromosomal replication after the replication fork has stalled. It is 
important in transformation in Neisseria, though it is unclear if it is involved in 
DNA import or later in recombination [103].   
Single stranded DNA binding proteins are thought to bind to the DNA once 
it enters the cytoplasm to prevent reverse translocation [104].  These proteins 
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include single-strand DNA-binding protein (Ssb) and DprA [77, 105].  This 
binding also helps prevent DNA degradation. DprA is also required for loading 
RecA onto incoming DNA, and this step is required for homologous 
recombination [105].  
Helicobacter pylori competence machinery 
As noted earlier, H. pylori uses a T4SS to transport DNA across the 
membranes.  There is also a similar system in C. jejuni but it is not the major 
transformation system, at least in laboratory settings [5, 31].  These systems are 
highly similar to the machinery used in conjugation. The crystal structure of the 
outer membrane components of the H. pylori system, VirB, has been determined 
[106].  This revealed an unexpectedly large structure of 17.2 nm with a 3.2 nm 
pore [106].  In vivo, it is likely that this pore is smaller because the VirB2 protein, 
thought to coat the inner portion of the channel, was not included in this 
structure.  As might be expected with such a large pore as well as a completely 
different transport structure, the initial steps of DNA transport appear to be 
different in H. pylori. Loose contact of the DNA with the outer pore appears to 
take place and pilus retraction could play a role in uptake [101]. What happens to 
the DNA once it enters the periplasm is unclear as well, because H. pylori lacks a 
comE homolog.  However, the pilin VirB2 binds to DNA in Agrobacterium and 
might functionally replace ComE [107]. After transport across the outer 
membrane, transport across the inner membrane in H. pylori appears similar to 
that of other competent bacteria.  It uses a ComEC homolog to translocate the 
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DNA into the cytosol [101]. Once in the cytosol, the DNA is bound by single-
stranded DNA binding proteins such as Ssb, DprA, and RecA [56].  
1.3.4 Recombination 
Transforming DNA enters the cytosol single-stranded.  From this state, it 
must recombine in order to complete the transformation process.  This process 
has been most well studied in S. pneumoniae so I will use that model for this 
discussion. When the ssDNA enters the cytoplasm, it is incorporated into a 
nucleoprotein complex [108, 109].  In this state, termed eclipse, the DNA is not 
capable of recombining onto the chromosome but it is protected from DNases 
[110]. In S. pneumoniae, eclipse lasts about 10 minutes at 37°C after which the 
DNA has integrated onto the chromosome [105].  The recombination process 
requires RecA, SsbB and DprA [105]. SsbB binds most of the incoming ssDNA, 
protecting it from DNases [105]. DprA binds either to the SsbB bound DNA and 
replaces it or to the free ssDNA[105]. DprA can then facilitate the loading of 
RecA [105]. RecA catalyzes heteroduplex formation and subsequent 
recombination [105].  This step requires a high degree of homology between the 
transforming DNA and the existing gDNA [111]. 
1.4 DNA selection during natural transformation 
While natural transformation can be beneficial to the recipient cell, it can 
also result in the acquisition of deleterious mutations.  Therefore, bacteria have 
evolved a number of mechanisms to select DNA during natural transformation, 
preferring to use DNA from closely related bacteria.  Some of these methods are 
specific for transformation, whereas others work on the other forms of HGT, 
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conjugation and transduction. The methods I will discuss are restriction-
modification (RM) systems, DNA uptake sequences (DUS), co-regulation of 
competence with quorum sensing, active DNA release, and CRISPR-Cas. 
1.4.1 Restriction Modification systems 
Restriction modification systems (RM systems) enable bacteria to combat 
phage infections.  All endogenous DNA is modified using a DNA 
methyltransferase (MTase) which protects the DNA from degradation by a 
cognate restriction enzyme (REase).  When a phage injects its DNA into the cell, 
it will lack the appropriate modifications and therefore be degraded by the 
REases.  There are many types of these systems which will be discussed in 
depth in Section 1.5.  In this section, I will examine how bacteria use these 
systems to select the DNA they use as a substrate for natural transformation.    
Helicobacter pylori encodes a large number of RM systems. The J99 and 
26695 strains are predicted to encode up to 26 putative RM systems [112]. One 
of those systems, M.HpyAXII/R.HpyAXII, targets GTAC sites and restricts 
unmethylated plasmid and chromosomal DNA during natural transformation 
[112]. Other RM systems, RM. Hpy188III and RM.HpyCH4V, act similarly.  These 
systems also decrease the length of the DNA that recombines onto the 
chromosome [113].  This was determined by assessing the endpoints of DNA 
that recombined onto the chromosome by genome sequencing in strains 
containing or lacking the RM systems [114].  Similarly, Pseudomonas stutzeri 
JM300 also uses an RM system to select DNA during natural transformation, 
though the exact system was not described [115].  The NlaIV RM system is 
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found in 19/20 Neisseria meningitidis strains as well as in other Neisseria strains. 
This system restricts plasmid transformation but does not restrict the transfer of 
DNA that is homologous except for a point mutation encoding antibiotic 
resistance [116].  DpnA, a MTase that targets ssDNA, is also important during 
transformation in Streptococcus pneumoniae [117]. This MTase is induced during 
competence and is important for acquisition of large, unmethylated pieces of 
DNA during transformation [117].  However, this MTase is not required for 
transformation of point mutations, even if the incoming DNA is not methylated 
[117].  
In all of these examples, it is unclear how a REase, which always targets 
dsDNA could target the ssDNA that is transported into the cell during natural 
transformation.  Claverys et al propose an elegant model to address this question 
which also explains the discrepancy that has been demonstrated between how 
these systems succeed in targeting the transfer of antibiotic cassettes but not of 
point mutations [117]. In this model, incoming unmethylated ssDNA with 
sufficient homology successfully recombines onto the chromosome creating DNA 
that is me0/me+ (gDNA is fully methylated (me+) whereas the incoming DNA lacks 
the proper methylation (me0)). The transfer of a cassette results in a bubble of 
single stranded, unmethylated DNA.  The transfer of a point mutation does not 
create this bubble as there is only one base pair difference.  Any DNA in the 
me0/me+ form can be methylated by endogenous DNA MTases and this results in 
two fully methylated strands of DNA (me+/me+).  The DNA in the cassette, as it is 
still single stranded, cannot be methylated.  DNA replication occurs. The newly 
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synthesized strand is unmethylated (me0). In the case of the cassette transfer, 
this results in a double-stranded region lacking methylation (me0/me0) that can be 
degraded by REases.  This is in contrast to the point mutant, which had been 
methylated by the endogenous MTases and now is me0/me+ and thus is resistant 
to REase activity [117].  
1.4.2 DNA Uptake Sequences 
Some bacteria recognize a specific sequence in order to select the DNA 
they utilize in transformation.  Termed DNA uptake sequences (DUS), these are 
10-12 base pair sequences that are overrepresented in the genomes of the 
bacteria that carry them.  They tend to occur approximately once per kilobase 
and tend to be enriched at genes associated with genome maintenance [118]. 
They have been identified in Neisseria species as well as H. influenza [119-121].  
In Neisseria, this DUS (5’-ATGCCGTCTGAA-3’) is recognized by a component of 
the Tfp.  ComP is a minor pilin that is highly conserved throughout the Neisseria 
and was demonstrated to bind to the DUS in a sequence-dependent manner 
[95].  Although this sequence was thought to be absolutely required for 
transformation in Neisseria, more recent work demonstrated that different 
isolates do not require the transforming DNA to contain a DUS, though it does 
increase the transformation efficiency [122].  The DUS has also been shown to 
increase the transformation efficiency of ssDNA, which has an overall lower 
efficiency than otherwise identical dsDNA [123].  
1.4.3 Quorum sensing/competence peptide 
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Linking competence to QS allows the bacterium to induce competence 
only in environments enriched for DNA from highly related individuals. 
Competence has been extensively studied in the Gram positive bacteria Bacillus 
subtilis and Streptococcus pneumoniae which have similar, though independently 
evolved mechanisms for regulating competence [124].  In both of these systems, 
competence genes are activated by small competence pheromones or peptides 
[81, 125].  These peptides are secreted and then recognized by two component 
systems that transmit the signal to activate the competence specific transcription 
factor that then turns on the competence regulon [80, 82, 126-128].  In B. subtilis, 
this peptide is called ComX and in S. pneumoniae, it is called CSP [81, 125].  
Both of these peptides activate competence in a cell density dependent manner.  
In B. subtilis, competence is induced during stationary phase but only in about 
10% of cells [129, 130]. In S. pneumoniae, CSP induces competence during 
early exponential phase and most cells become competent, but they only stay 
competent for approximately 15 minutes [78, 131]. While this mechanism is 
reminiscent of QS, these microbes do not strictly depend on cell density to 
induce signaling.  Instead, CSP accumulation (and therefore sensing) can be 
induced by external cues as well as cell density and can be better described as 
cell-cell signaling  [37, 79]. These systems allow for competence to be tightly 
regulated and induced by contact (through peptides) with other, closely related 
cells.  This increases the likelihood that the DNA these cells take up is similar to 
their own.  
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In Gram negative bacteria, the link between QS and competence has 
primarily been studied in Vibrio cholerae. This bacterium expresses competence 
genes using tfoX which is induced by growth on chitin [72, 132]. As Vibrio 
species normally inhabit aquatic environments where they colonize the chitinous 
surfaces of zooplankton, this allows for the induction of competence in the 
natural environment. Transformation is more efficient at high cell density, 
indicating a role for QS [47, 72].  HapR, the master regular of QS, represses the 
eDNase Dns [47]. When Dns is present, it degrades DNA before it can be used 
by the competence system [47, 133]. HapR is also a positive regulator of comEA 
and pilA [48, 72, 134]. V. cholerae also produces two autoinducers, CAI-1 and 
AI-2 [135, 136].  CAI-1 functions as a Vibrio specific signal where AI-2 is a more 
general autoinducer and can be made and sensed by many different types of 
bacteria [135-137].  Correspondingly, strains deficient in CAI-1 are almost 
completely deficient in natural transformation whereas the defect for strains 
lacking AI-2 is much smaller [48, 77, 134].  This indicates that Vibrio has 
optimized its expression of competence genes in order to preferentially take up 
DNA from closely related bacteria.  However, as competence is still initiated by 
AI-2, it can also take up DNA from more distantly related species, enabling 
greater genetic diversity.  Because of its species specificity and its role in natural 
transformation, CAI-1 is termed a competence pheromone, similar to CSP in S. 
pneumoniae [48, 77].  
1.4.4 Active DNA release 
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Similar to QS, some bacteria secrete bacteriocins or autolysins that result 
in the release of DNA.  When these systems are coregulated, competence is 
turned on in an optimal situation to acquire DNA.  In many cases, the bacteria 
are closely related and this increases the odds of taking up similar DNA.  This 
has been best characterized in S. pneumoniae which produces fratricide 
effectors.  These are bacteriolytic cell wall hydrolases that work on bacteria 
closely related to the producer strain. They are also co-regulated with the 
competence genes and are only produced after the bacteria have upregulated 
competence [66, 138].  Fracticide immunitiy is induced upon induction of 
competence, but sibling cells that have not become competent are susceptible to 
these effectors and are killed, providing a source for DNA [65, 66, 138]. In 
addition to fracticide effectors, S. pneumoniae produces bacteriocins to compete 
with other bacteria, including within mammalian hosts. Different strains express 
unique bacteriocins with corresponding immunity proteins. Bacteriocin production 
is co-regulated with the competence system [42, 78].  The bacteriocin locus is 
induced by the competence pheromone, CSP [42]. Bacteriocins kill neighboring 
cells lacking the proper immunity, leading to increased availability of DNA that 
the competence system can use [42].  Furthermore, the bacteriocin pheromone 
can be secreted by the competence system, leading to increased synergy 
between these two systems [42]. Unlike fracticide effectors that will only work on 
non-competent cells, bacteriocins have the potential to work on many other 
closely related cells because even if the cell has become competent and 
upregulated its bacteriocin locus, it may lack the correct immunity factors.  This 
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can increase the likelihood the induction of competence will result in the uptake 
of DNA.  
T6SS enable bacteria to directly inject effector proteins into other bacterial 
cells in order to kill them.  As previously discussed, in V. cholerae, competence is 
co-regulated with QS.  It is also co-regulated with the V. cholerae T6SS.  The 
master regulator of competence, TfoX, also induces the T6SS.  Likewise, the 
T6SS is turned on when V. cholerae grows on a chitin surface.  Killing as a result 
of T6SS activity also triggers uptake of DNA in the predator cells, indicating a 
functional link between the activation of T6SS and competence [63].  
1.4.5 CRISPR Cas Systems 
CRISPR (Clustered, regularly interspaced, short palindromic repeat) loci 
are essentially sequence specific bacterial immune systems and primarily defend 
against phage attack, though they work against conjugative plasmids as well.  
The CRISPR loci consist of arrays of short, approximately 40bp, repetitive 
sequences separated by short spacer sequences.  The spacers are derived from 
(and are therefore specific to) mobile genetic elements such as phage DNA. 
When a phage injects its DNA into a cell containing a CRISPR that contains 
spacers specific to that phage derived from an earlier encounter, CRISPR RNAs 
(crRNAs) are transcribed and are used as guides by the CRISPR associated 
(Cas) genes to bind to and degrade the incoming DNA in a sequence specific 
manner. It has been assumed that this system could not work against 
transforming DNA as half of the time the incoming DNA would not match the 
spacer because that strand was degraded. However, in both S. pneumoniae and 
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N. meningitidis CRISPR can target DNA brought into the cell through natural 
transformation [139, 140].  
S. pneumoniae does not normally encode a CRISPR/Cas system; Bikard 
et al moved the CRISPR loci from Streptococcus pyogenes SF370 into S. 
pneumoniae [139]. They also engineered spacers that would target incoming 
chromosomal DNA during natural transformation.  When the transforming DNA 
did not match the spacer, equal transformation efficiencies were observed for 
both CRISPR containing and WT strains [139].  However, when the transforming 
DNA matched the spacer, no transformants were observed for the CRISPR 
containing strain whereas the WT strain had no change in transformation 
efficiency [139].  They further demonstrated that this system worked inside an 
animal model [139].   Although this demonstrated that CRISPR/Cas could work 
against transforming DNA, it was in an artificial system and did not explain how 
the incoming single-stranded transforming DNA could be targeted by a system 
that is extremely sequence specific.  
Zhang et. al., identified a naturally occuring CRISPR/Cas system in N. 
meningitidis that encoded spacers to other Neisseria genomes and demonstrated 
that this CRISPR/Cas system could prevent natural transformation [140]. Where 
targets could be putatively identified, all the spacers targeted other Neisseria 
strains, ranging from other N. meningitidis genomes to N. gonorrhoeae and N. 
lactamica [140]. When a N. meningitidis strain containing the CRISPR/Cas 
system was transformed with DNA matching the spacers, no transformants were 
obtained [140].  However, when the transforming DNA did not match the spacers, 
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this strain was readily transformed [140]. This effect was independent of the 
vector used, the integration locus, or the selection marker and worked for many 
spacers, as long as they shared homology with the transforming DNA [140].  
Neisseria primarily uses natural transformation, as opposed to conjugation or 
transduction, to acquire genetic diversity.  The fact that the spacer arrays 
primarily target other related Neisseria strains indicate this CRISPR/Cas might be 
a mechanism to select DNA. This is in contrast to other mechanisms described 
thus far where systems are optimized to take up closely related DNA. In this case 
Neisseria selects for DNA that is not closely related.  This could help explain the 
extensive genetic diversity found in these species.  
Although neither study offered an explanation for how the CRISPR system 
could efficiently target incoming ssDNA without a strand bias, Johnston et. al. 
provide a hypothesis similar to the mechanism for ssDNA targeting by RM 
systems [141].  Essentially, they propose that CRISPR/Cas targeting does not 
occur until after the first round of replication.  At this point, the DNA is double 
stranded again, so targeting can occur independent of which strand was brought 
into the cell.  Secondly, because CRISPR/Cas is efficient and there is no 
mechanism to avoid targeting, unlike RM systems, this also explains how no 
transformants are ever identified.  For RM systems, occasional transformants are 
found presumably because the MTase can methylate the me0/me0 DNA before 
the REase degrades it [141].  
1.4.6 Production of extracellular DNases 
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Campylobacter strains have not been described to have any of the 
previously described mechanisms of limiting or selecting DNA during 
transformation.  However, certain C. jejuni strains produce extracellular DNases 
(eDNases) that can degrade DNA non-specifically, preventing it from being used 
for transformation. Three different eDNases have been identified, dns, Cje0556 
and Cje1441 [49, 50].  The presence of a single eDNase is sufficient to eliminate 
transformation and strains encode between zero and three eDNases [49, 50, 
142].  42% of sequenced Campylobacter strains do not encode any of the 
nucleases [142].  Only 13% of genomes contained more than a single eDNase 
and only 0.9% of strains contained all three [142]. These nucleases are also 
encoded on integrated elements indicating they might be transferred among 
strains [49, 50].  Thus far, regulation of these nucleases and of the competence 
genes has not been described. Like the case with V. cholerae and its eDNase 
dns, there may be a condition(s) where the strains encoding these nucleases 
become competent by turning them off and upregulating the competence genes.  
1.5 DNA Methyltransferases and Restriction Modification Systems 
MTases are enzymes that attach a methyl group to a DNA base.  There 
are three different groups based on which carbon on which base the methyl 
group is attached to: N6-methyladenine (m6A), N5-methylcytosine (m5C), or N4-
methylcytosine (m4C) [143].  m6A enzymes specifically methylate the amino 
group at the C-6 position of adenines. m4C MTases specifically methylate the 
amino group at the C-4 position of cytosines while m5C methylate the C-5 carbon 
of cytosines [143]. Work in bacteria has primarily focused on m6A and to a lesser 
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degree m4C MTases.  This has been due both to the prevalence of m6A MTases 
in bacterial genomes as well as the lack of straightforward method for detecting 
methylated bases. Single-molecule real-time (SMRT) sequencing has allowed for 
the easy detection of modified bases during genome sequencing, especially of 
modified adenines [144].  SMRT sequencing uses unamplified DNA as the 
sequencing template and then measures the amount of time it takes to add a 
new base to the growing strand. Bases that have already been modified cause 
the DNA polymerase to add the next base more slowly [144].  From this kinetic 
data and the sequence it is possible to infer which base is modified [144]. 
Modified cytosines are not detected with as high degree of accuracy so these 
motifs, and the enzymes that provide them, have been less studied [144].  
In bacteria, DNA MTases are often part of RM systems [145].  As 
previously discussed, these systems function to protect the bacterial genome 
from incoming DNA, whether that is bacteriophage DNA or DNA from other 
bacteria brought in through conjugation or natural transformation.  The 
endogenous DNA contains a certain methylation pattern based on the MTases 
encoded in its genome.  These methyl marks prevent the cognate REases from 
degrading the chromosome because methylation inhibits cleavage, except for 
Type IV RM systems.  Incoming DNA will lack the proper methylation and so 
becomes a target for the REases and can then be degraded, protecting the host 
chromosome. As of this writing, over 12,000 bacterial and archaeal genomes 
have been sequenced. Of those, only 4% do not contain a single RM system 
(http://rebase.neb.com). As of 2010, nearly 4000 enzymes had been identified 
 30 
 
with about 300 different specificities. This was from only 2,450 bacterial and 
archaeal genomes  [146]. As the number of sequenced genomes has increased 
dramatically, there are likely to be many more identified enzymes and 
specificities.  In a recent study of 230 newly SMRT sequenced genomes, 
215/230 genomes had DNA modification [147].   Generally speaking, the number 
of RM systems increases with the size of the genome with outliers in 
Helicobacter, Campylobacter  and Neisseria which contain proportionally more 
RM systems for the size of their genomes [147, 148].  The presence of more RM 
systems also correlates with naturally competent bacteria [148].  Bacteria that 
are not competent tend to have fewer systems compared to those of similar 
genome size that are competent. Notably, those bacteria previously indicated to 
be outliers above are all naturally competent.  As discussed earlier, this indicates 
a role for RM systems in protecting the genome, especially among bacteria that 
specifically bring in DNA. There are four major different types of these systems: 
Type I, Type II, Type III and Type IV.  
1.5.1 Type I RM systems 
Type I systems are not well characterized and are complex.  There are 
three polypeptides that function together in a complex.  They are named after 
their function: R for restriction, M for modification, and S for specificity.  The 
complex formed by these polypeptides is R2M2S1.  This complex contains both 
restriction and modification capabilities.  The S subunit recognizes the target 
domain as well as binds to the DNA.  The recognition sequence for Type I RM 
systems is complex and asymmetrical.  There are typically two halves separated 
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by a series (between six and nine) of nonspecific bases.  The methyltransferase 
domain generally modifies adenines in each half of the recognition sequence. 
This polypeptide contains both a SAM (S-adenosylmethonine) binding motif and 
methyltransferase activity. The R subunit is the largest and cleaves DNA at a site 
distant, between ~100 bp to tens of thousands of base pairs from the recognition 
sequence. [148]  This complex is large—the R subunit is approximately one 
thousand amino acids while the M and S subunits are between 450 and 500 
amino acids.  
Ten total strains of Campylobacter, ranging from C. jejuni to C. 
subantarcticus, have had their methylomes been determined by SMRT 
sequencing [149-153].  However, all the genes responsible for these motifs have 
not been experimentally determined. For the sake of this review, I will focus on 
identified RM systems in the C. jejuni strains 81-176 and 11168. They have been 
SMRT sequenced and all motifs have been matched to RM system genes. They 
share one Type I system in common which recognizes the motif 
TAAYN5TGC/ATTRN5ACG [149].  Here, methylated bases are indicated by 
underlining. This system is made up of Cj81176_0776 (M), 0777 (S), and 0780 
(R) in 81-176 and Cj1549c (R), 1551c (S), and 1553c (M) in 11168.   In addition, 
81-176 has an additional type I system that recognizes the motif 
CAAYN6ACT/GTTRN6TGA, made up of Cj81176_1534 (R), 1536 (S), and 1539 
(M) [149].  Both of these motifs have been confirmed to be methylated by SMRT 
sequencing, indicating these systems are active. Most other SMRT sequenced 
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Campylobacter strains contain at least one active Type I system [150-153] .  The 
exception is C. subantarticus LMB24377 which has none [152].  
1.5.2 Type II RM systems 
Type II systems are the most well studied of the RM systems and are 
generally the simplest.  The REases require divalent cations, usually Mg2+.  The 
REases generally act as homodimers (except Type IIT); each cuts one strand of 
the DNA resulting in a double stranded break.  Most recognize short DNA 
sequences, usually four to eight base pairs long [154]. These are highly utilized 
in genetic engineering. This family is also very heterogenous because this 
grouping is based on enzymatic activity as opposed to phylogeny. [155]  There 
are over 350 prototype systems in this family.  Because of this diversity, these 
systems have been further divided into subgroups [155]. These families overlap 
so each unique RM system can also belong to multiple families.  
Type IIP enzymes recognize palindromes and cleave at fixed symmetrical 
locations.  These can be within the sequence or immediately adjacent [156]. 
EcoRI is an example of this type.  It recognizes the palindrome GAATTC and 
cleaves within the sequence. As EcoRI was one of the first REase identified, it is 
the prototype for this family [156].  
The Type IIC family includes all enzymes that have a hybrid structure in 
which all enzymatic activity is encoded on one polypeptide [156].  All members of 
Type IIB, IIG, and some Type IIH are also included in this family [156]. Type IIB 
systems have REases that cleave on both sides of the recognition sequence 
[156].  Type IIG enzymes are a subtype of the of Type IIC family.  The 
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distinguishing characteristic of these enzymes is that SAM is critical—it can 
stimulate or inhibit activity [156].  Type IIA and IIP enzymes are sometimes 
members of the IIG family. Type IIH enzymes have a gene structure similar to 
Type I, with different polypeptides encoding each function, but enzymatically 
function as Type II enzymes [156].  
Type IIA RM systems recognize asymmetric recognition sequences [156]. 
Members of this family have REases that cleave either in the sequence or away 
from it [156].  Generally, they have one REase and two MTase genes [156].  This 
is because each MTase must modify a different sequence on each strand of 
DNA.  For these systems, the recognition sequences are similar to Type IIB. 
Type IIS enzymes are a subset of Type IIA enzymes [156].  They cleave 
asymmetrically and at least one cleavage occurs outside of the recognition 
sequence [156].  
Type IIE systems have enzymes that require two copies of the recognition 
sequence to be functional [156].  One of the sites is cleaved and the other is the 
allosteric effector [156]. EcoRII is an example of this type of enzyme. Similar to 
Type IIE, IIF enzymes also require two copies of the recognition sequence but in 
this case, both copies are cleaved [156].  BspMI and NgoMIV are examples of 
this type of enzyme. Type IIT systems have REases that are composed of 
heterodimers.   
All of the identified Type II systems in C. jejuni are Type IIG systems [26, 
149]. This means that SAM is critical for these systems and that all enzyme 
activity is encoded in one polypeptide. Both 81-176 and 11168 share one active 
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Type II system in common and this system recognizes GCAAGG [149].  It is 
encoded by CJJ81176_0713 in 81-176 and Cj0690c in 11168.  81-176 has an 
additional system, encoded by CJJ81176_0068 that recognizes GGRCA [149]. 
11168 has two more systems that are active.  The first is encoded by Cj1051c, 
and recognizes GAGN5GT [26, 149].  The second system is encoded by Cj0031c 
[26].  This gene has a polyG tract of eight to ten base pairs two-thirds of the way 
through the gene [26].  These leads to phase variation in which the system 
becomes inactivated. This enzyme recognizes the sequence CCYGA [26]. All 
SMRT sequenced strains of Campylobacter have been found to have at least 
one active Type II system and many have more [149-153].  
1.5.3 Type III 
Type III systems have features of both Type I and Type II systems.  Like 
Type II, the R and M subunits are separate proteins, but the M subunit confers 
the specificity for both functions.  The REase requires ATP in order to cleave the 
DNA and the MTase requires SAM in order to methylate the DNA.  Like Type I 
systems, Type III systems recognize asymmetric sequences.  Type III systems 
function as heterotrimers (M2R1) or heterotetramers (M2R2) [148].  These 
enzymes compete among themselves for modification or restriction within the 
same catalytic cycle [148]. They recognize short, asymmetric sequences of five 
or six base pairs [148]. Once a sequence is recognized, the complex translocates 
approximately twenty-five basepairs down the DNA and cleaves the 3’ side of the 
target [148]. The DNA is only cleaved when two recognition sequences are in an 
inverse orientation with respect to each other [148]. There have not been any 
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active Type III systems identified in 81-176 or 11168.  One is predicted for 
RM1221 which has not been SMRT sequenced so it is not known if this system is 
active.  
1.5.4 Type IV (Mcr-like) systems 
Type IV systems cut modified DNA as opposed to unmodified DNA. They 
most commonly cut methylated DNA but they have also been demonstrate to cut 
phosphorothioated (PT) DNA, hydroxymethylated or glucosyl-hydroxymethylated 
DNA [148, 157]. PT is a modification in which a sulfur atom replaces the non-
bridging oxygen in the phosphate backbone. This modification creates linked 
dinucleotides: d(APSA), d(CPSA), d(CPSC), d(GPSA), GPSG, d(TPSA), and d(TPSC) 
[158]. Very little sequence specificity is required for these enzymes. In many of 
the identified systems, cleavage requires NTP hydrolysis; various members have 
been found to require diverse NTPs including UTP, CTP, GTP, dATP, and ATP 
[159]. These enzymes have been hard to identify because in order to identify 
them, a functioning genetic system is required [159]. As of 2010, of the 1303 
putative Type IV REases in REBASE, only three had been biochemically 
characterized [157]. The rest were bioinformatic predictions.  
McrBC-like RM systems have not been identified in either 11168 or 81-176.  
However, both strains do encode McrBC-like genes [160].  In 11168 these genes 
are encoded by  Cj0139 and Cj0140 and in 81-176 by CJJ81176_0174, 0175, 
and 0176 [160].  
1.5.5 Orphan MTases 
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Finally, there is a group of DNA MTases that do not work with a cognate 
REase.  This family is termed orphan MTases.  Like the MTase polypeptides or 
proteins of the other families, these methylate specific sequences.  These 
enzymes have not been demonstrated to play a role in RM systems.  The well 
characterized ones, Dam in E. coli and CcrM in Cauliobacter crescensus, have a 
number of roles from gene regulation to cell cycle progression.  These orphan 
MTases tend to have higher conservation as compared to MTases that are 
involved in restriction modification systems.  There is also a link between 
hypomethylation and gene regulation at sites specific to orphan MTases.  
Dam MTase is highly conserved throughout the γ-Proteobacteria.  It is a 
SAM-dependent MTase that methylates the adenine in the motif GATC and plays 
a role in regulating the cell cycle.  In many species, such as V. cholerae and 
Yersina enterocolitica Dam is required [161, 162]. In other species, such as 
Salmonella enterica and Klebsiella pneumoniae, it is required for virulence [161, 
163].  In E. coli it plays a role in mismatch repair, the SOS response and 
interactions with host cells [164-167].  This MTase regulates many genes 
although the mechanism is not clear in all cases.  In the cases where the 
mechanism has been determined, there is a competition between other DNA 
binding proteins and Dam.  These proteins bind to promoter regions in a 
methylation dependent manner. The DNA binding proteins Lrp and OxyR prefer 
un-methylated or hemi-methylated DNA respectively.  This has been 
demonstrated for the regulation of the pap operon in E. coli in which Lrp and PapI 
compete with Dam for the promoter. This is also true for agn43, involved in the 
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synthesis of non-fimbrial adhesions, in which OxyR and SeqA compete with Dam 
[168, 169]. This mechanism seems consistent with the distribution of GATC sites, 
which accumulate more in the promoter regions as opposed to coding regions 
[164-166].  
CcrM was first identified in C. crescensus and methylates adenines in 
GANTC motifs with a preference for hemi-methylated DNA [170, 171]. This 
MTase is tightly regulated during the cell cycle and only accumulates in pre-
divisional cells, coinciding with the end of replication [170].  It is required for 
viability in C. crescensus, Rhizobium meliloti, Agrobacterium tumefaciens and 
Brucella abortus [170-173]. Furthermore, overexpression of this MTase results in 
cells that have more than one chromosome as well as other cell cycle defects.  
For B. abortus, CcrM overexpression results in attenuated replication in mouse 
macrophages [173].  Like Dam, CcrM regulates many other genes and the 
mechanism is similar.  This can be demonstrated for the regulation of dnaA.  This 
gene, located near the origin, has two GANTC sites in the promoter and 
functions best when fully methylated.  Upon chromosomal replication, this site 
becomes hemi-methylated, decreasing the efficiency of transcription from the 
promoter. It remains in this state until CcrM accumulates and can methylate the 
promoter [174, 175].  CcrM has also been demonstrated to regulate ctrA P1 
which plays a role in the initiation of DNA replication and is a master 
transcriptional regulatorv [176].  Finally, CcrM regulates its own transcription 
because transcription from ccrM is repressed by CcrM [177].  This promoter is 
also activated by CtrA[178].  
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Orphan MTases are widespread. A recent paper reported at least one 
active orphan MTase in 111 sequenced species spread among 15/20 phyla 
analyzed [147].  They also made an observation that these MTases tend to be 
more evolutionarily conserved than MTases that are part of RM system.  They 
found 57% of orphan MTases are conserved at the genus level compared to 9% 
of those that are part of RM systems [147].  While the conservation decreases 
somewhat when comparing family and class, orphan MTases are still significantly 
more conserved at these levels [147]. This has also been demonstrated 
bioinformatically where there is a much higher probability that an orphan MTase 
will be conserved than one in a RM system [179].  
When orphan MTases are grouped into families based on recognition 
motif and the taxonomic relationship between host organisms, Dam-like and 
CcrM-like MTases were most common [147].  The third most common family 
methylates the motif 5’-RAATTY-3’ and was found in six Spirochaetaceae as well 
as ten sequenced Campylobacter strains [147, 149-153].  Orphan MTases also 
seemed to operate distinctly from those in RM systems.  Generally, all the sites 
in a genome are methylated when the methylation was associated with a MTase 
from functional RM system [147]. In contrast, there are distinct patterns of 
hypomethylation associated with orphan MTases [147].  This had previously 
been demonstrated for Dam MTase in E. coli. This is the result of competing 
activities of Dam and regulatory proteins and can lead to epigenetic modifications 
of gene expression [180-182]. Considering RAATTY methylation, both 
Spirochaetaceae and Campylobacter were enriched in hypomethylated sites 
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relating to transcription [147, 153].  However, whether this plays a functional role 
in gene regulation has not been demonstrated.  
Based on SMRT sequencing, only one active orphan MTase has been 
identified in all SMRT sequenced Campylobacter strains [149-153].  As described 
above, this methylates the motif RAATTY and is identified as EcoRI-like because 
this recognition sequence is a more general version of the EcoRI recognition 
sequence, GAATTC.  This is the only active orphan MTase that has been found 
in either 81-176 or 11168 [149].  However, both are predicted to encode at least 
nine more though they were not found to be active (Table 1.1)  [160]. The role of 
this conserved orphan MTase will be discussed in more detail in Chapter III.   
11168 81-176 
Cj0495 CJJ81176_0516 
Cj0722c CJJ81176_0745 
Cj0590 CJJ81176_0618 
Cj0976 CJJ81176_0995 
Cj0979c CJJ81176_0998 
Cj1300 CJJ81176_1314 
Cj1325 CJJ81176_0207 
Cj1419c CJJ81176_1418 
Cj1420c CJJ81176_1419 
Cj1426c  
Table 1.1: Predicted orphan adenine methyltransferases. Gene designations are given 
for each predicted MTase.  Genes on the same line share homology.  
 
1.6 Transformation in C. jejuni 
1.6.1 Genes required for transformation 
As previously noted, C. jejuni can encode up to two distinct competence 
machineries [5, 31].  One of those, encoded on a plasmid (Vir), resembles the H. 
pylori T4SS machinery while the other encoded on the chromosome (Cts), 
resembles T2SS or Tfp, similar to other competent bacteria.  Loss of essential 
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components of the Vir system led to at best one half-log decrease in 
transformation efficiency whereas loss of any of Cts components resulted in the 
inability to detect transformants [5].  Because of this, I have focused my work on 
the Cts system and that is the system I will detail here. For a model of the C. 
jejuni Cts competence system, see Figure 1.   
By performing a transposon screen, Wiesner et. al., identified the major 
components of a Tfp/T2SS system.  These genes were named based on 
homology to previously characterized competence genes and termed them 
Campylobacter transformation system proteins (cts). They include those 
encoding a secretin, ctsD; pseudopilins, ctsG and ctsT; two ATPases, ctsP and 
ctsE; and as a structural component of these systems, ctsF.  Also identified was 
a gene encoding a transmembrane protein that has no overall homology to other 
proteins and termed ctsX [5].  While potential pseuopilins have been identified, C. 
jejuni has never been demonstrated to produce a pilus. This leads us to 
hypothesize that retraction of a pseudopilus, as opposed to a pilus, opens up a 
gap in the secretin CtsD, which then allows DNA to enter the cell. Interestingly, 
C. jejuni does express two transformation-associated ATPases, CtsE and CtsP. 
CtsE is most similar to more typical production ATPases whereas CtsP is not 
similar to retraction ATPases [183].  However, retraction of pseudopili—as 
opposed to bona fide pili—may require an ATPase of a different specificity.  The 
roles of these two ATPases as well as CtsX, the required membrane protein of 
unknown function, will be discussed more in Chapter II.  
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recA was the first gene identified to be required for transformation in C. 
jejuni [184].  DprA is also required for both natural transformation as well as 
electroporation with plasmid DNA [185]. This phenotype is similar to that in H. 
pylori, indicating these proteins behave similarly in both systems [185].   
Cj0011c is a ComE/ComEA homolog required for transformation [186].  It 
is a non-specific DNA binding protein capable of binding to ssDNA and dsDNA 
[186]. Like ComE in Neisseria, it localizes to the periplasm of C. jejuni and is not 
surface exposed [186]. The  transformation defect of cells lacking Cj0011c is less 
severe than that of B. subtilis cells lacking ComEA [28, 186]. This indicates that 
C. jejuni might have additional DNA binding proteins that function during 
transformation.  
Cj1211c is also required for competence in C. jejuni [187]. This protein 
had a strong degree of homology to H. pylori ComE3 but not to other functional 
ComE3 homologs such as ComEC in B. subtilis and ComA in N. gonorrhoeae 
[187]. These proteins function as the inner membrane translocator.  Although it is 
required for transformation in C. jejuni, a Cj1211c mutant has no DNA binding 
and uptake defect [187].  As the binding and uptake assay measures if the DNA 
becomes resistant to eDNases (i.e. the DNA is transported inside the outer 
membrane of the cell), this phenotype indicates a role downstream of initial 
import. This includes transporting the DNA to the cytosol once it has been 
brought into the periplasm and so Cj1211c could be the inner membrane 
translocator in C. jejuni.   
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N-linked protein glycosylation (pgl) has also been shown to have an effect 
on transformation. When insertional mutations were made in two key genes in 
this process, pglB and pglE, there was a significant defect in transformation 
[188].  The authors initially investigated this phenotype because of VirB10, a 
component of the Vir competence system with a glycosylation motif [188]. 
However, the glycosylation of VirB10, which does affect its function, is not 
sufficient to explain the defect [188].  The transformation defect in pgl insertional 
mutants is greater than in a strain lacking a functional Vir system.  Thus far, no 
other competence proteins have been found to be targets of glycosylation.  
Polyphosphate (poly-P) kinases have also been demonstrated to be 
important for transformation in C. jejuni [189].  These enzymes play roles in 
bacterial survival and stress tolerance [190, 191]. A Δppk1 strain had an 
approximately 1.5 log defect in natural transformation [189].  In other bacteria, 
PPK1 is important for the production of cell membrane channels that allow for 
DNA uptake [190, 191].  Whether this is the role of PPK1 in C. jejuni was not 
determined.  
As I previously described the role of eDNases on transformation in Section 
1.4.6, I will just summarize the previous section.  C. jejuni can produce up to 
three eDNases and all are capable of inhibiting natural transformation.   
1.6.2 Regulation 
As described previously, bacteria regulate competence to different 
degrees.  Some such as H. pylori and N. gonorrhoeae are constitutively 
competent whereas others such as S. pneumoniae and B. subtilis carefully 
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regulate this process.  C. jejuni is competent in all growth phases, though there is 
some variation in the efficiency.  The highest transformation efficiency observed 
(10-4) occurred in exponential growth and the efficiency decreased during 
stationary phase (10-6) [2]. There is also an inverse relationship between CO2 
concentrations and transformation efficiency.  C. jejuni grows best at higher CO2 
concentrations (~10%).  At 10% CO2, the average transformation efficiency was 
10-4 but as the CO2 concentration was decreased to 5% and 0.7% the 
transformation efficiency rose to about 10-3 and 10-2 respectively [2].  This might 
indicate that C. jejuni is more competent in times of stress, such as low CO2 
concentrations. The loss of transformation efficiency in stationary phase was not 
as dramatic at low CO2 concentrations [2].  
The effect of temperature and oxygen levels on transformation has also 
been measured.  Temperature in the normal growth range of C. jejuni, 37°C and 
42°C, had minimal effect on transformation, though there were more 
transformants at 42°C [1]. As the temperature decreased to 30°C or 20°C 
degrees, transformation dropped significantly and essentially no transformants 
were detected at 20°C [1].  Oxygen levels also affected transformation.  
Anaerobic conditions were inhibitory to transformation at all temperatures [1].   
Microaerobic and aerobic conditions were much more favorable, with the best 
transformation efficiency seen in microaerobic conditions at 42°C [1].   
pH also has an effect on transformation.  At pH levels from 7 to 11, the 
transformation efficiency remained stable at 10-3 [1]. There was a precipitous 
drop in transformation efficiency outside of this window [192].  This is contrast to 
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the vitality of the cells.  Cells grew best at pH 7 but at higher pHs, approximately 
60% or fewer cells were able to survive [1].  
As has been previously described for other systems and concurrent with 
our data concerning the Cts ATPases in Chapter II, transformation requires 
energy.  When overall cellular energy was depleted either with HQNO or sodium 
azide, transformation was inhibited [1].  This was true either if the cells were 
treated prior to transformation or during transformation [1].  
Finally, transformation requires active translation but not active 
transcription. In the presence of transcription inhibitors, transformation is not 
affected but when translation inhibitors such as erythromycin and tetracycline are 
added, transformation is inhibited [1].  The mechanism that might require 
translation but not transcription for natural transformation has yet to be 
determined. 
1.6.3 DNA selection 
It has been described that C. jejuni and C. coli are selective for the DNA 
that they use in transformation [2, 193].  In C. coli, uptake of radiolabeled C. coli 
gDNA was able to be outcompeted by unlabeled C. jejuni or C. coli DNA but not 
by E. coli derived DNA [193]. Campylobacter does not seem to contain a 
conventional DNA uptake sequence.  Furthermore, DNA purified from E. coli or 
generated via PCR, does not transform WT cells. However when identical DNA is 
purified from C. jejuni, the DNA transforms as well as C. jejuni gDNA, the 
preferred substrate.  This indicates that selection is not based on sequence per 
se.  Cj1051c has been reported to play a role in DNA selection in C. jejuni strain 
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11168 [194].  However, this gene is not conserved among all Campylobacter 
strains and is therefore not sufficient to explain the overall specificity of 
Campylobacter [194]. The mechanism of DNA selection will be discussed in 
Chapter III.  
1.6.4 In vivo transformation 
Most work studying C. jejuni transformation has used in vitro conditions.  
However, transformation has been examined in the in vivo conditions of both the 
chicken intestinal tract and biofilms.  C. jejuni is well adapted to colonize chicken 
intestine and different strains colonize the intestine simultaneously [195]. It was 
hypothesized that because multiple strains could be present, transformation 
could occur in the chicken.  This was tested experimentally by coinfecting 
chickens with strains containing two different antibiotic markers and looking for 
double resistant strains [3]. These were detected in every group tested as early 
as two days post infection and as late as 29 days post infection. This work was 
flawed in some respects because the rate of transformation was not calculated. 
Thus it was not determined if the double-resistant colonies that appeared to be 
transformants were the result of independent genetic exchanges or the 
expansion of one successful transformation [3].  
Similar to other competent species such as S. pneumoniae, C.jejuni 
makes biofilms.  This is thought to be one way it survives in water in the 
environment. Genetic exchange has been demonstrated in biofilms in vitro [4].  
This transformation occurs at a higher rate in the biofilms than for planktonic cells 
and transformation is abolished in the presence of added DNases [4].  
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Furthermore, the biofilm itself is thought to contain DNA as biofilm formation is 
reduced in the presence of DNases [4, 196].  
1.7 Conclusions 
Natural transformation is a trait of many diverse bacteria. Despite the 
diversity of bacteria, the machinery used to transport the DNA into the cell is 
highly homologous in many species, resembling a T2SS or Tfp.  Despite the 
similarity in the machinery used, these systems have diverse regulatory 
mechanisms ranging from constitutive expression in N. gonorrhoeae of the 
competence genes to brief, synchronized expression in S. pneumoniae. Many 
different mechanisms exist to optimize DNA uptake, especially DNA from similar 
bacteria.  Some use uptake sequences to select for similar DNA. Others co-
regulate competence with the expression of bacteriocin genes to promote active 
DNA release.  Another uses CRISPR Cas and many uses RM systems.  
    DNA MTases are also widespread across the bacterial phyla.  Most 
bacteria encode at least one and it is often a part of a RM system.  These 
systems protect the bacteria from incoming DNA and are more common in 
naturally competent bacteria.  The four types of RM systems differ in how they 
recognize DNA, how the enzymes are encoded on the genome, and how they 
modify the DNA.  Orphan MTases are more widely conserved than MTases that 
are in RM systems.  Two of these, Dam and CcrM, have been well studied and 
are involved in gene regulation.  Many more orphan MTases have recently been 
identified and bioinformatic and sequencing data support the hypothesis that 
these newly identified orphan MTases play a role in gene regulation as well. 
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 C. jejuni is a Gram negative, commensal of avian species and pathogen of 
some mammalian species including humans. The species exhibits a great deal of 
genomic diversity. This is at least partially attributable to the fact that it is capable 
of all three mechanisms of HGT.  Natural transformation has been studied in this 
bacteria and genes important for this process have been identified.  Like most 
other bacteria, these genes look like a T2SS or Tfp system.  C. jejuni is highly 
selective in the DNA it uses for transformation though it does not seem to encode 
a conventional uptake sequence.  The degree of competence varies in different 
environmental conditions, but in all conditions tested, the bacteria are competent 
unless eDNases are also expressed.  Finally, competence is even active in in 
vivo conditions such as chick intestinal tracts and biofilms. 
1.8 Thesis outline 
 The central goal of this thesis was to examine to aspects of C. jejuni 
natural transformation.  In Chapter II, I examine individual components of the 
transformation machinery. I focus on the two identified ATPases, CtsP and CtsE, 
and the protein that has no overall homology to those in other systems, CtsX.  I 
look at the requirement of these proteins in transformation as well as how they 
localize.  With a former student, I determine that these proteins are required for 
transformation and that while the two ATPases are similar to other competence 
ATPases, these have unique characteristics regarding their membrane 
localization. We also determine that CtsX is a transmembrane protein that can 
interact with CtsP, though we still do not understand its role in competence.  In 
Chapter III, I investigate at the process of DNA selection in C. jejuni. I explore a 
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methylation pattern that is required for transformation and demonstrate that a 
single, methylated motif on the DNA is sufficient for transformation by that DNA, 
independent of its origin.  I demonstrate that selection must occur inside of the 
cell, though the exact mechanism is yet to be determined.  In Chapter IV, I 
summarize the findings of this thesis and identify questions that have yet to be 
answered.  
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CHAPTER II 
 
CHARACTERIZATION AND LOCALIZATION OF THE CAMPYLOBACTER 
JEJUNI TRANSFORMATION SYSTEM PROTEINS CTSE, CTSP AND CTSX   
 
2.1 Abstract 
The human pathogen Campylobacter jejuni is naturally competent for 
transformation with its own DNA.  Genes required for efficient transformation in 
C. jejuni include those similar to components of type II secretion systems found 
in many Gram negative bacteria [5].  Two of these, ctsE and ctsP, encode 
proteins annotated as putative nucleotide binding NTPases or NTP binding 
proteins.  Here we demonstrate that the nucleotide binding motifs of both 
proteins are essential for their function in transformation of C. jejuni.  Localization 
experiments demonstrate that CtsE is a soluble protein while CtsP is membrane-
associated in C. jejuni.  A bacterial twohybrid screen identified interaction 
between CtsP and CtsX, an integral membrane protein also required for 
transformation.  Topological analysis of CtsX using LacZ and PhoA fusions 
demonstrate it to be a bitopic, integral membrane protein with a cytoplasmic 
amino terminus and a periplasmic carboxyl terminus.  Notwithstanding its 
interaction with membrane-localized CtsX, CtsP inherently associates with the 
membrane, requiring neither CtsX or several other Cts proteins for this 
association.     
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2.2  Introduction 
The Gram-negative bacterium C. jejuni is a leading cause of bacterial 
gastroenteritis worldwide [197].  C. jejuni often colonizes the avian intestinal tract 
and, consequently, a common route of infection is through consumption of 
contaminated poultry [198].   
 A number of Campylobacters are naturally competent for transformation, 
meaning that they can take up macromolecular DNA from the environment and 
incorporate it heritably into their genomes [2, 193].  The ability to acquire DNA 
from the environment may contribute to the extensive genetic diversity observed 
among strains of C. jejuni [17, 18].  Horizontal gene transfer in vivo has been 
demonstrated during experimental infection of chicks, a natural host for this 
pathogen [3]. 
 Multiple genes whose products are involved in natural transformation of C. 
jejuni have been identified [5, 31, 185, 188, 199].  Using transposon mutagenesis 
and a genetic screen for loss of competence, we isolated mutations that mapped 
to 11 genes encoded in C. jejuni strain 81-176 [5].  Mutations in these result in 
reduction in transformability to levels four orders of magnitude below wild type 
[5].  Among these are six genes arranged in a likely operon, some of which 
encode proteins similar to components of type II secretion and type IV pilus 
biogenesis systems and are homologous to proteins important for natural 
transformation in other organisms [200].  Two of these, ctsE and ctsP, encode 
putative NTPases or NTP binding proteins, according to the annotated genome 
of C. jejuni strain 11168 [5, 21].  
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 CtsE is a member of the type II secretion/type IV secretion system 
superfamily of NTPases collectively referred to as the PulE - VirB11 family [183, 
201].  Members of this family are involved in diverse processes including 
secretion, pilus biogenesis, competence for natural transformation, and 
conjugation [183].  PulE – VirB11 family members share several elements, 
including the nucleotide-binding motifs – Walker boxes A and B – an Asp box, 
and a His box [202-204].   CtsE also has a tetra-cysteine motif conserved among 
the GspE and PilB/HofB subfamilies [205, 206]. 
 ATPase activity has been demonstrated in vitro for several members of 
the PulE - VirB11 family [207-211]. It is hypothesized that this activity powers the 
transformation process, though this has yet to be conclusively shown. 
Phylogenetic analyses placed CtsE in the type II secretion subfamily of NTPases; 
in one such analysis CtsE fell between the ComG1 subfamily of Gram-positive 
NTPases involved in competence and the PilT and PilU subfamily involved in 
retraction of type IV pili [183, 201].  Another analysis placed CtsE in the Gram-
positive competence subfamily, closely related to the GspE subfamily of type II 
secretion machinery  [201]. Although ATPase activity has not been demonstrated 
for most of the type II secretion machinery, it has been hypothesized.  
CtsE is one of two putative identified NTP binding proteins important for 
natural transformation of C. jejuni.  The other is CtsP [5], which has Walker box A 
and B nucleotide binding motifs, but lacks other characteristics of the PulE – 
VirB11 superfamily including the His box, the Asp box and the tetra-cysteine 
motif.  By BLAST analysis CtsP exhibits weak homology to several ATPases 
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including PilT homologues, ClpX ATP binding subunits, and members of the AAA 
family of ATPases.  The Walker boxes of CtsP resemble those of the AAA+ 
superfamily, but CtsP does not appear to have the minimal AAA consensus 
sequence [203, 212].   
In this study we characterized CtsE and CtsP, the two putative 
NTPases/NTP binding proteins required for natural transformation of C. jejuni.  
We also carried out analysis of a third gene product encoded in the cts gene 
cluster, CtsX, unique to the C. jejuni transformation system.  CtsX lacks 
significant sequence homology to other proteins, and shares no clearly 
conserved domains beyond a transmembrane domain.  We determined 
subcellular localization of each of these proteins, and we investigated the roles of 
the nucleotide binding motifs in CtsE and CtsP.  Further analysis investigated 
protein-protein interactions among constituents of the type II-like Cts system in C. 
jejuni [5], revealing association between CtsP and CtsX. 
 
2.3 Results 
2.3.1  The Walker Boxes of CtsE and CtsP are required for function in vivo 
The Walker boxes A and B are conserved nucleotide binding motifs important for 
NTPase function [204], and both motifs are present in CtsP and CtsE.  To 
determine the contribution of CtsP and CtsE for natural transformation of C. jejuni 
we tested whether Walker box motifs are important in vivo.  Carboxyl-terminal 
FLAG fusions to each protein were expressed C. jejuni ΔctsP and ΔctsE 
mutants;  the fusion proteins complemented the respective mutant alleles to near 
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wild-type levels of transformation, similar to complementation observed with 
untagged alleles of ctsP or ctsE  (Figure 2.1). [5] 
 
Figure 2.1. Transformation efficiency of C. jejuni CtsE and CtsP mutants.  
Strains are complemented with pECO102, pECO102 expressing the wild-type 
coding sequence with a C-terminal FLAG tag, or pECO102 expressing the 
coding sequence with a Walker Box mutation and a C-terminal FLAG tag.  The 
data represent the average of three samples per strain from one experiment.  
Experiments were repeated at least three times with similar results. Error bars 
indicate standard deviation. The limit of detection is indicated with a dashed line. 
Stars indicate p values calculated using one-way ANOVA with Dunnett’s multiple 
comparison test. 
 
Walker box A (GxxxxGK(S/T), where x is any amino acid) forms a loop 
structure (the P-loop) in which the lysine can directly contact the phosphoryl 
group of the bound nucleotide [213, 214].  This Walker box motif is important for 
the function of many PulE – VirB11 superfamily members and mutation of 
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invariant residues abolishes ATP binding in a number of proteins [202, 215-217].  
The conserved lysine codon (K296) of the Walker box A in ctsE was changed by 
site directed mutagenesis to encode a glutamine in CtsE-FLAG (CtsE-FLAG 
K296Q), which was expressed in a ΔctsE strain to determine whether it could 
restore transformation.  While the FLAG-tagged version of CtsE could 
complement a CtsE deletion mutant, the Walker Box A point mutant in CtsE 
(CtsE-FLAG K296Q) could not (Figure 2.1).  Immunoblotting confirmed that 
CtsE-FLAG K296Q was expressed at levels similar to CtsE-FLAG (data not 
shown).   
 Several alleles of ctsP-FLAG with alterations to the same Walker box A 
lysine proved unstable (data not shown), preventing functional assessment of 
Walker box A in CtsP; we thus targeted Walker box B in CtsP for mutagenesis. 
The conserved sequence of Walker box B is hhhhDExx, where h is a 
hydrophobic amino acid and x is any amino acid.  The coding sequence for the 
conserved glutamic acid residue (E81) was changed by site-directed 
mutagenesis to encode an alanine residue in CtsP-FLAG, which was stable (by 
immunoblotting, data not shown).   CtsP-FLAG E81A was unable to complement 
a ΔctsP mutant (Figure 2.1). Through these site-directed mutagenesis studies we 
have determined that intact nucleotide binding motifs are required for the function 
of both CtsE and CtsP in transformation. 
2.3.2  Localization of CtsE and CtsP 
Members of the PulE – VirB11 superfamily of NTPases are hypothesized to act 
at the inner membrane of Gram-negative bacteria through association with 
 55 
 
membrane-localized proteins within their respective transport systems. To 
assess localization of CtsP-FLAG and CtsE-FLAG, C. jejuni strains expressing 
either fusion protein were fractionated into soluble and insoluble fractions as 
described previously [218]. The soluble fraction contains the cytoplasmic and 
periplasmic contents and the insoluble fraction contains the inner and outer 
membranes.   Activity of isocitrate dehydrogenase, a cytoplasmic enzyme, was 
monitored to determine the purity of the fractions [218].  Immunoblot analysis of 
these fractions using anti-FLAG monoclonal antibody revealed different 
subcellular locations for these two putative NTPases.  CtsP-FLAG was detected 
primarily in the membrane fraction, while CtsE-FLAG was located primarily in the 
soluble fraction (Figures 2.2A and 2.2B).  To determine whether the cytoplasmic 
localization of CtsE-FLAG resulted from competition for membrane binding 
partners with the chromosomally encoded version of CtsE, we assessed 
localization of CtsE-FLAG in a ΔctsE background.  The tagged protein was still 
observed primarily in the cytoplasmic fraction in the absence of native CtsE 
(Figure 2.2B).   
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Figure 2.2. Localization of CtsE, CtsP, and CtsX fusion proteins.  Cellular 
fractions of DRH212  expressing CtsP-FLAG (A), CtsE-FLAG (B), or His-CtsX 
(C) from pECO102 or ΔctsE expressing CtsE-FLAG (B) were separated by 12% 
or 15% SDS-PAGE.  The presence of the CtsP-FLAG and CtsE-FLAG fusion 
proteins was detected by immunoblotting using a monoclonal antibody against 
FLAG.  His-CtsX was detected using a monoclonal antibody against His. S, 
soluble fraction, M, membrane fraction.  
 
2.3.3  Bacterial two-hybrid screen for identification of Cts interaction 
partners 
CtsP localizes to the membrane fraction of C. jejuni, but does not have a 
predicted hydrophobic region that could serve as a transmembrane domain.  We 
hypothesized that interaction with another protein might be responsible for the 
membrane localization of CtsP.   To explore this, we used a bacterial two-hybrid 
system based on functional reconstitution of adenylate cyclase activity [219].  For 
two-hybrid analysis, we tested the competence genes ctsE, ctsX, ctsF, ctsD, 
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ctsR, all of which are encoded contiguously with ctsP, and ctsG, ctsW, and dprA, 
which are unlinked to ctsP.  Genes were cloned into both pT18 and pT25, two 
plasmids that provide different domains of adenylate cyclase.  We tested for 
interactions between all Cts proteins.  Two different protein-protein interactions 
among Cts proteins were identified (Figure 2.3).  One was between CtsE-T18 
and T25-CtsE, which is consistent with observations that GspE proteins in other 
type II transport systems form multimers, [211, 220, 221] suggesting that CtsE 
may form a multi-monomer complex.  
 
Figure 2.3. β-galactosidase assays of bacterial two-hybrid system interactions.  
When fused to proteins that interact, the T25 and T18 fragments of adenylate 
cyclase are able to associate leading to cAMP synthesis resulting in transcription 
of lacZ.  For a positive control, T25 and T18 are fused to a leucine zipper (zip) 
[219].  Activities represent the average of three samples from one experiment 
which was repeated at least three times with similar results.  Error bars indicate 
standard deviation.  
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 The other interaction we identified was between CtsP-T18 and T25-CtsX 
(Figure 2.3); ctsX is encoded immediately downstream of ctsP [5]. Based on 
Kyte-Doolittle hydropathy analysis, CtsX is predicted to be a membrane protein 
by virtue of a single putative transmembrane helix from amino acid 21 to 40. To 
test this experimentally, we expressed a His-CtsX fusion protein in C. jejuni 
DRH212.  Cells were fractionated into soluble and membrane fractions as 
discussed above for CtsE and CtsP, and fraction purity was assessed by 
isocitrate dehydrogenase assays (data not shown).  His-CtsX was detected by 
immunoblotting with an anti-His monoclonal antibody.  As predicted, the majority 
of the His-CtsX fusion protein was located in the membrane fraction (Figure 
2.2C). 
 The membrane topology of CtsX was experimentally determined using β-
galactosidase and alkaline phosphatase fusions to the CtsX coding sequence.  
Alkaline phosphatase is active only when transported outside of the cytoplasm 
[222], whereas β-galactosidase is active in the cytoplasm.  Portions of the CtsX 
coding sequence at different positions on both sides of the predicted 
transmembrane region of CtsX were fused in frame with lacZ and phoA reporter 
genes in pTrcLacZ and pTrcPhoA [223]. 
  The first 14 amino acids of CtsX directed high level β-galactosidase 
activity but low level alkaline phosphatase activity indicating that the N-terminus 
of the protein resides in the cytoplasm (Figure 2.4).  In contrast, fragments of 
CtsX including the putative transmembrane domain directed low β-galactosidase 
levels, but high alkaline phosphatase activities (Figure 2.4)., consistent with there 
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being a transmembrane domain in the protein as predicted by the Kyte-Doolittle 
plot.   Based on these data, we predict that small portion of the N terminus of 
CtsX is localized to the cytosol, with the remainder of the protein within the 
periplasmic space.    
 
Figure 2.4. Topology studies of CtsX.  Reporter protein activity levels of E. coli 
TG1 expressing four fragments of ctsX in a translational fusion with lacZ (left) or 
with phoA (right). Data represent the average of three samples from one 
experiment that was repeated at least three times with similar results.  Error bars 
indicate standard deviation. Stars represent p-values calculated using Student’s 
unpaired t test.  
 
2.3.4   Localization of CtsP in the absence of other Cts proteins 
Because CtsP lacks an obvious membrane localization signal and interacts with 
CtsX, which is membrane localized, we hypothesized that membrane localization 
of CtsP depends on CtsX.  However, CtsP-FLAG localized to the membrane 
fraction in mutant cells lacking ctsX, (Figure 2.5A), as well as in mutants lacking 
other transformation genes including ctsF, ctsE, ctsD, ctsR, and ceuB ([5];  
Figure 2.5B and data not shown).  To test whether membrane localization of 
CtsP requires any C. jejuni proteins, we expressed CtsP-FLAG in E. coli JM101.  
Membrane localization was still observed (Figure 2.5C), suggesting either that 
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membrane localization is an intrinsic feature of CtsP, or that a protein with which 
it interacts and co-localizes is also present in E. coli.    
 
Figure 2.5. Localization of CtsP in the absence of other Cts proteins.  Localization of 
CtsP-FLAG.  (A & B)  Cellular fractions of DRH212 or cts mutants or (C) cellular 
fractions from E. coli JM101 expressing CtsP-FLAG from pECO102 were separated by 
12% SDS-PAGE.  The presence of the CtsP-FLAG fusion protein was detected by 
immunoblotting using a monoclonal antibody against the FLAG epitope.  S, soluble 
fraction, M, membrane fraction. 
 
 To rule out that the overexpressed protein is simply insoluble and thus 
pellets with membranes in the fractionation experiments described above, we 
tested membrane association of CtsP using a membrane flotation assay. 
Membrane flotation assays utilize a sucrose gradient to separate the membranes 
from any insoluble proteins that will pellet during ultracentrifugation. Using this 
 61 
 
assay, we observed that while some CtsP does become insoluble (in fraction 6), 
the majority is located in membrane containing fractions (fractions 2-5). This is 
true when CtsP-FLAG is expressed in wild type cells, as well as in ΔctsP, ΔctsX, 
or ΔctsE strains. Even when CtsP-FLAG is expressed in E. coli, it is primarily 
localized to the membrane containing fraction and not the insoluble fraction 
(Figure 2.6). 
 
Figure 2.6. Membrane flotation of CtsP-FLAG. Soluble and membrane fractions 
of DRH212, cts mutants (ΔctsP, ΔctsE, and ΔctsX), and E. coli containing the 
fusion protein CtsP-FLAG expressed on pECO102 were obtained. The 
membrane fractions were resuspended in a sucrose gradient to separate the 
membranes from the insoluble material, subjected to ultracentrifugation, and 
fractions were taken moving sequentially down the gradient (numbered 1-6 
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where 1 is the top of the gradient and 6 contains the insoluble proteins). These 
fractions were separated via 12% SDS-PAGE. The presence of the CtsP-FLAG 
fusion protein was detected by immunoblotting using a monoclonal antibody 
against the FLAG epitope.  S, soluble fraction, M, membrane fraction. 
 
2.3.5  Membrane Extractability of CtsP and CtsX 
Given its fractionation with the membrane of both C. jejuni and E. coli, we 
hypothesized that CtsP is a peripheral membrane protein, perhaps associating 
with the membrane by interacting with the polar head of the phospholipid bilayer.  
In contrast, CtsX, with its more obvious transmembrane domain and the fusion 
protein’s ability to localize alkaline phosphatase to the periplasmic space (Figure 
2.4), appears to be an integral membrane protein.   To further characterize CtsP 
and CtsX as integral or peripheral membrane proteins, we analyzed the avidity of 
their association with C. jejuni membranes using different extraction procedures 
commonly used to release peripherally associated membrane proteins [224]. 
Membranes of C. jejuni expressing CtsP-FLAG or His-CtsX were treated 
with high salt (1 & 2 M NaCl, 1 M KCl), urea (3 M, 5 M) or extremes of pH  
(Na2CO3 pH 3.0, pH 11.0) for 30 minutes at 4C as described in Materials and 
Methods.  Control membranes were treated with 10 mM Tris, pH 8.0.   CtsP-
FLAG was partially extracted from the membranes in high salt (1 & 2 M NaCl, 1 
M KCl) while CtsX remained predominantly membrane associated (Figure 2.7).  
Treatment of the membranes with urea (3 M, 5 M) nearly completely solubilized 
CtsP-FLAG while His-CtsX was only partially extracted by this treatment (Figure 
2.7).  Membrane treatment with 0.5 M Na2CO3 at pH 11 also extracted CtsP-
FLAG into the soluble fraction (Figure 2.7).  In contrast, Na2CO3 treatment was 
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not sufficient to affect His-CtsX localization. It remained in the membrane fraction 
after (Figure 2.7).  These results suggest that while His-CtsX is an integral 
membrane protein, the more ready extraction of CtsP-FLAG suggests that it is 
not integral but peripheral to the membrane, interacting with it perhaps through 
an as-yet undefined mechanism.  
 
Figure 2.7. Membrane extractability of CtsP-FLAG and His-CtsX.  Membranes 
were incubated with the indicated reagents for 30 min at 4C and sedimented by 
ultracentrifugation.  Separated fractions were examined by 12% or 15% SDS-
PAGE.  Fusion proteins were detected by immunoblotting with anti-FLAG M2 
antibody for CtsP-FLAG and with an anti-6x His antibody for His-CtsX.  S, soluble 
fraction after washes, M, membrane fraction. 
 
 
2.4  Discussion 
The goal of this study was to characterize two putative NTPases/NTP binding 
proteins involved in natural transformation of C. jejuni.  One of these, CtsE, 
belongs to a family of well-studied NTPases involved in transport of 
macromolecules in a number of systems including type II secretion, type IV 
secretion, and type IV pilus biogenesis [183, 201].  Members of this family have 
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ATPase activity in vitro [207-211], although the exact ATP-dependent step in 
transport is unclear.  Given the homology of CtsE to other members of this family 
and the importance of an intact Walker box A for CtsE to function in natural 
transformation, it is likely that CtsE has ATPase activity critical for its role in 
transformation. 
 The other putative NTPase/NTP binding protein, CtsP, has little homology 
to other NTPases and cannot be assigned to a defined family. CtsP Walker box 
A mutants were all unstable in C. jejuni, but a stable mutant protein lacking 
Walker box B was unable to correct the transformation defect of a ΔctsP mutant.  
We suggest that CtsP may bind and hydrolyze nucleotides and that this property 
is necessary for natural transformation of C. jejuni, although further work is 
needed to determine whether CtsP has ATPase activity.   
 Transformation in C. jejuni involves a number of proteins with similarity to 
those required for pilus biogenesis and natural transformation in Neisseria 
gonorrhoeae and Vibrio cholerae[5, 225-227], [228, 229]. In these species, 
transformation is facilitated by the production of a pilus that is produced and 
retracted through the power of two ATPases. Transformation in N. gonorrhoeae 
requires the activity of two ATPases, PilF and PilT [225, 230] and in V. cholerae it 
requires PilB and PilT [228].  Both N. gonorrhoeae ATPases are members of the 
PulE – VirB11 superfamily [183, 201].  PilF is required for elaboration of the pilus 
while PilT is required for retraction [225, 231].  As noted, while CtsE appears to 
fall into this family, CtsP does not. However, unlike these two systems, C. jejuni  
has never been shown to produce a pilus (1) and lacks a homolog to the major 
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structural subunits found in these systems, PilE in N. gonorrhoeae and PilA in V. 
cholerae. Instead, C. jejuni contains a number of genes that may encode 
pseudo-pilins:  ctsG, ctsT, and Cjj81176_1096; two of these have been shown to 
function in transformation [5].  Whether a pilus or pseudo-pilus is responsible for 
DNA binding or uptake across the outer membrane,  requiring the actions of CtsE 
and CtsP, has yet to be determined. In the V. cholerae transformation system, 
pseudopilins are thought to initiate pilus formation while the major pilin subunit, 
PilA, is then responsible for the pilus structure [228]. Loss of any of these 
proteins leads to approximately a three-log decrease in transformation efficiency 
[228]. Similarly to the V. cholerae system, the pseudopilins in C. jejuni may be 
sufficient to induce transformation. A second possibility is that unlike in the V. 
cholerae system, the pseudopilins might also form enough of a pilus-like 
structure to facilitate transformation even without the presence of a major pilin 
subunit.  
 CtsE appears to be predominantly cytosolic in C. jejuni, whereas CtsP is 
predominantly membrane-associated.  A CtsE homologue, ComGA, involved in 
transformation of Bacillus subtilis localizes to the membrane in that species, 
where it behaves as a peripheral membrane protein [232].  In some other 
bacteria, CtsE homologues (generally termed GspE proteins) become membrane 
localized by interacting with an integral membrane protein generally termed GspL 
[233, 234] but no GspL homologue was identified in the C. jejuni genome 
sequence.   It is difficult to imagine how CtsE could play a role in the early stages 
of transformation unless it interacts with proteins at the membrane. In the Vibrio 
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cholerae system, a GFP tagged version of the CtsE homolog, PilB, forms 
dynamic foci at the membrane that transiently overlap with other components of 
the Vibrio transformation apparatus [228].  Perhaps similarly to the Vibrio system, 
a transient, or very weak, association of CtsE occurs with the membrane and this 
could have been disrupted during fractionation; this might account for the small 
amount of CtsE-FLAG observed in the membrane fraction.  
 Unlike CtsE, CtsP localizes to the membrane in C. jejuni, where it may 
interact with other components of the transformation machinery.  By bacterial 
two-hybrid analysis we detected interaction between CtsP and CtsX, another 
protein necessary for efficient C. jejuni transformation.  CtsX is encoded 
immediately downstream of CtsP in a putative operon [5].  CtsX is an integral 
membrane protein with its amino terminus exposed to the cytoplasm, and 
residues 50 – 195 in the periplasm.  Interaction with CtsX is not necessary for 
CtsP localization to the membrane, nor is interaction with several other 
components of the transformation machinery.  CtsP behaves as a peripheral 
membrane protein and it may associate directly with the membrane.  This 
possibility is strengthened by the membrane localization of CtsP-FLAG observed 
during expression in E. coli.  If membrane localization required interaction with 
another protein, it would have to be present in E. coli as well and would likely not 
be involved in natural transformation, a process that has not been described in E. 
coli.  As noted above, type II secretion system GspE family members, with which 
CtsE shares homology, associate with the membrane through interaction with 
another protein, GspL.  When these GspE family members are expressed in E. 
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coli cytoplasmic localization is observed [235], which differs from our observed 
localization of  CtsP to membrane fractions in E. coli.  Further study is needed to 
confirm that CtsP directly associates with the membrane.  Furthermore, we were 
able to replicate the membrane association phenotype using membrane flotation. 
If this association were an artifact of the initial fractionation procedure, we would 
expect to see CtsP-FLAG associate predominately with the insoluble aggregate 
and not float with the membranes. One possibility that has yet to be discounted 
definitively is that the CtsP-FLAG localization (as well as that of CtsE-FLAG) is 
due to studying plasmid-encoded proteins, rather than the chromosomally-
encoded native protein.   But the behavior of the plasmid-encoded, FLAG-tagged 
proteins mitigates this concern, because both CtsE-FLAG and CtsP-FLAG 
restore transformation efficiency of their respective mutant strains to near wild 
type levels.  
CtsX and CtsP represent novel components of the C. jejuni transformation 
machinery.   Homologues of CtsX have not been identified in other 
transformation systems and BLAST analysis does not provide obvious clues 
about its function.  As it resides largely in the periplasm, perhaps its C-terminus 
interacts with other components of the transformation machinery in that 
compartment.  CtsX and CtsP are encoded in a putative operon between the 
type II secretion/type IV pilus biogenesis system homologues ctsD, ctsE, and 
ctsF.  Given the CtsX/CtsP interaction, we hypothesize that these two proteins 
comprise a component of type II secretion/type IV pilus biogenesis systems 
specifically involved in C. jejuni competence.  Perhaps the interaction is required 
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for assembly or translocation of other transformation components, or it allows 
assembly of a structure needed specifically for DNA uptake and not pilus 
biogenesis. 
2.5 Materials and Methods 
2.5.1 Bacterial strains and media 
 Bacterial strains used in this work are listed in Table 2.1.  C. jejuni was 
routinely cultured on Muller Hinton (MH) agar with 10% sheep’s blood in 
microaerophilic conditions (5% CO2, 10% O2, balanced with N2) in a tri-gas 
incubator at 37C.  When necessary, media was supplemented with antibiotics in 
the following concentrations: trimethoprim (10 g ml-1), kanamycin (as noted, 
either 30 or 150 µg ml-1), streptomycin (100 g ml-1), and chloramphenicol (as 
noted, either 20 or 30 g ml-1).  All C. jejuni strains were stored at -80C in MH 
broth with 20% glycerol. 
Escherichia coli strains were routinely cultured at 37C in Luria-Bertani 
(LB) broth or agar.  When necessary, antibiotics were used at the following 
concentrations: ampicillin (100 g ml-1), chloramphenicol (30 g ml-1), kanamycin 
(50 g ml-1), and tetracycline (12.5 g ml-1).  All E. coli strains were stored at -
80C in LB broth with 20% glycerol. 
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Table 2.1.  Strains and plasmids used in this study 
Strain or 
Plasmid 
Relevant characteristics Reference 
   
Bacteria   
   
E. coli   
DH5 supE44 ΔlacU169 (Ф80lacZΔM15) hsDr17 recA1 endA1gyrA96 
thi-1 relA1 
Lab strain 
JM101 F’ traD36 proA+B+ lacIq Δ(lacZ)M15/Δ(lax-proAB) glnV thi New England Biolabs 
DH5 
pRK212.1 
contains conjugative plasmid for transferring DNA into 
Campylobacter 
[236] 
Sp850 lam-, el4-, relA1, spoT1, cyaA1400(::kan), thi-1 E. coli Genetic Stock 
Center, Yale  
TG1 ΔhsdS Δ(lac-proAB) supE thi F0[traD36 proAB+ lacI’qΔlacZM15] Lab strain 
   
C. jejuni   
81-176 clinical isolate [237]  
DRH153 81-176 astA::aphA3; Knr [238] 
DRH212 81-176 rpsLSm [238] 
RSW46 DRH212 ctsX [5] 
RSW53 81-176 ceuB::solo [5] 
RSW57 81-176 ctsD::solo [5] 
RSW58 81-176 ctsF::solo [5] 
RSW115 DRH212 ctsP [5] 
RSW136 DRH212 ctsE [5] 
   
Plasmids   
pT18 encodes T18 fragment of CyaA [219] 
pT25 encodes T25 fragment of CyaA  [219] 
pT18-Zip encodes T18 fragment in frame with 35 aa leucine zipper [219] 
pT25-Zip encodes T25 fragment in frame with 35 aa leucine zipper [219] 
pTrcLacZ pTrc99A with the ‘lacZ gene (lacks codons Met 1 to Ser 7) [223] 
pTrcPhoA pTrc99A with the ‘phoA gene (lacks codons Met 1 to Met 26) [223]  
pECO102 pRY112 derivative with cat promoter in XhoI-BamHI sites [5] 
pRSW176 pT18 with ctsP in XhoI-ClaI sites This study 
pRSW184 pT25 with ctsX in PstI-BamHI sites This study 
pRSW186 pT25 with ctsE in PstI-BamHI sites This study 
pRSW191 pT18 with ctsE in XhoI-ClaI sites This study 
pRSW206 
pRSW208 
pECO102 with N terminal His tag in frame with BamHI site 
pECO102 with ctsP and a C-terminal FLAG tag 
This study 
pRSW211 pECO102 with C-terminal FLAG tag in frame with XhoI site This study 
pRSW223 pRSW211 with ctsE in BamHI-XhoI site This study 
pRSW228 pRSW208 with E81A point mutation This study 
pRSW246 pRSW223 with K296Q point mutation This study 
pRSW248 pTrcLacZ w/coding seq for 1st 50 a.a. of ctsX in NcoI-XmaI site This study 
pRSW249 pTrcLacZ w/coding seq for 1st 100 a.a. of ctsX in NcoI-XmaI site This study 
pRSW250 pTrcPhoA w/coding seq for 1st 14 a.a. of ctsX in NcoI-XmaI site This study 
pRSW251 pTrcLacZ w/coding seq for 1st 14 a.a. of ctsX in NcoI-XmaI site This study 
pRSW252 pTrcPhoA w/coding seq for 1st 50 a.a. of ctsX in NcoI-XmaI site This study 
pRSW253 pTrcPhoA w/coding seq for 1st 100 a.a. of ctsX in NcoI-XmaI site This study 
pRSW254 pTrcPhoA w/coding seq of ctsX in NcoI-XmaI site This study 
pRSW255 pTrcLacZ w/coding seq of ctsX in NcoI-XmaI site This study 
pRSW256 pRSW211 with ctsX in BamHI-XhoI sites This study 
pJMB1 pRSW206 with ctsX in BamHI-XhoI This study 
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2.5.2 Construction of FLAG fusion proteins 
 To express FLAG fusion proteins in C. jejuni we modified pECO102 by 
mutagenesis with PFU turbo [5].  Two primers were made that annealed to 
pECO102 and would insert the coding sequence for the FLAG tag and a stop 
codon downstream of the XhoI site.  (All primers used in this study are indicated 
on Table 2.2.)  pECO102 was amplified by PCR with these primers and the 
template DNA was digested with DpnI.  E. coli DH5 was transformed with the 
reaction mixture and clones were screened by PCR.  Candidate plasmids were 
sequenced to confirm insertion of the FLAG sequence and one, pRSW211, was 
used for subsequent cloning.  To construct in-frame fusion proteins with a C-
terminal FLAG tag, PCR primers were designed to amplify the coding sequence 
of the protein of interest from the second amino acid through the last amino acid 
(excluding the stop codon).  The 5’ primer had BamHI sites and the 3’ primer had 
XhoI sites for in-frame insertion into pRSW211.  All subsequent clones were 
verified by sequence determination. 
Table 2.2.  Oligonucleotide primers used in this study 
 
Plasmid   Sequence            Site      Primer Name 
 
pRSW176  5’ CCCATCGATACCCTTAATAAGCCATTCTCTAAAGCACTAAGCTTT 3’ClaI  Cj1473c pT18 3’ 
pRSW176  5’ CCGCTCGAGGAGTAAAATTATTCCATTTAGAGAAGAAATTTTTC 3 ’ XhoI  Cj1473c pT18 5’ 
pRSW184  5’ CGCGGATCCCTACTTTCCATCTAATTCCATTAAACC 3’      BamHI Cj1472c pT25 3’ 
pRSW184  5’ AAAACTGCAGGGCAAGAAAGAATTAAAGAGCTTGAGCTTAGG 3’    PstI  Cj1472c pT25 5’ 
pRSW186  5’ CGCGGATCCTCATCTTACAACCCTTAAAAGCTCATC 3’      BamHI Cj1471c pT25 3’ 
pRSW186  5’ AAAACTGCAGGGGAAAGTAGAATGGATAAAATTTTTCAAGC 3’     PstI  Cj1471c pT25 5’ 
pRSW191  5’ CCCATCGATACTCTTACAACCCTTAAAAGCTCATCTATAC 3               ClaI      Cj1471c pT18 3’ 
pRSW191  5’ CCGCTCGAGGGAAAGTAGAATGGATAAAATTTTTCAAGC 3’     XhoI   Cj1471c pT18 5’ 
pRSW208  5’ CGCGGATCCAGTAAAATTATTCCATTTAGAGAAGAA 3’      BamHI  Cj1473c comp strt 
pRSW208  5’ CCGCTCGAGTTATTTGTCATCATCGTCCTTATAATCCCTTAAT     XhoI  Cj1473c comp stp  
                 AAGCCATTCTCTAAAGCACT 3’       FLAG 
pRSW211  5’ ATCAAGCTTATCGATACCGTCGACCTCGAGGATTATAAGGACG   pECO FLAG tag 1 
    ATGATGACAAATAAGGGGGGCCCGGTACCCAGCTTTT 3’ 
pRSW211  5’ AAAAGCTGGGTACCGGGCCCCCCTTATTTGTCATCATCGTCC  pECO FLAG tag 2 
    TTATAATCCTCGAGGTCGACGGTATCGATAAGCTTGAT 3’ 
pRSW223  5’ CGCGGATCCCAAAGTAGAATGGATAAAATTTTTCAAGCT 3’     BamHI  Cj1471c comp strt 
pRSW223  5’ CCGCTCGAGTCTTACAACCCTTAAAAGCTCATCTAT 3’      XhoI  Cj1471c no stp cod 
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pRSW228  5’ CAAGGTCAGAGTTAAATCATTCTTGATGCAGTGGGAATG   CtsP E81A 1 
    TATGATTATGCAA 3’ 
pRSW228  5’ TTGCATAATCATACATTCCCACTGCATCAAGAATGATTAA   CtsP E81A 2 
    ACTCTGACCTTG 3’ 
pRSW246  5’ AAACACGCGTATAAAGTTGTGCTTTGACCACTACCTGTAG   Cj1471c K296Q 1 
    GACCGGTTAAT 3’ 
pRSW246  5’ ATTAACCGGTCCTACAGGTAGTGGTCAAAGCACAACTTTA   Cj1471c K296Q 2 
    TACGCGTGTTT 3’ 
pRSW248  5’ CTCATCCATGGCGCAAGAAAGAATTAAAGAGCTTGAGCTT 3’     NcoI  CtsX fusion 5’ 
pRSW248  5’ TCCCCCCGGGAATATTTTTTTGCTTATTATATTTTTGCAT 3’     XmaI  CtsX 50 aa fus 3’ 
pRSW249  5’ CTCATCCATGGCGCAAGAAAGAATTAAAGAGCTTGAGCTT 3’     NcoI  CtsX fusion 5’ 
pRSW249  5’ TCCCCCCGGGTTTAACTTCTTCTAGTTCTTTATATAACTT 3’     XmaI  CtsX 100 aa fus 3’ 
pRSW250  5’ ACAATTTCACACAGGAAACAGACCATGCAAGAAAGAATTAAA    Nterm 14aa PhoA1 
    GAGCTTGAGCTTAGGTATAAATACTTTCCTGTTCTGGAAAAC 
    CGGGCTGCTCAG 3’ 
pRSW250  5’ CTGAGCAGCCCGGTTTTCCAGAACAGGAAAGTATTTATACCTA   Nterm 14aa PhoA2 
            AGCTCAAGCTCTTTAATTCTTTCTTGCATGGTCTGTTTCCTGTG 
    TGAAATTGT 3’ 
pRSW2515’ ACAATTTCACACAGGAAACAGACCATGCAAGAAAGAATTAAA   Nterm 14aa LacZ1 
     GAGCTTGAGCTTAGGTATAAATACTTTCTGGCCGTCGTTTTACA 
     ACGGGGATCC 3’   
pRSW251 5’ GGATCCCCGTTGTAAAACGACGGCCAGAAAGTATTTATACCT  Nterm 14aa LacZ2 
   AAGCTCAAGCTCTTTAATTCTTTCTTGCATGGTCTGTTTCCT  
   GTGTGAAATTGT 3’ 
pRSW252  5’ CTCATCCATGGCGCAAGAAAGAATTAAAGAGCTTGAGCTT 3’            NcoI  CtsX fusion 5’ 
pRSW252  5’ TCCCCCCGGGAATATTTTTTTGCTTATTATATTTTTGCAT 3’      XmaI  CtsX 50 aa fus 3’ 
pRSW253  5’ CTCATCCATGGCGCAAGAAAGAATTAAAGAGCTTGAGCTT 3’      NcoI  CtsX fusion 5’ 
pRSW253  5’ TCCCCCCGGGTTTAACTTCTTCTAGTTCTTTATATAACTT 3’      XmaI  CtsX 100 aa fus 3’ 
pRSW254  5’ CTCATCCATGGCGCAAGAAAGAATTAAAGAGCTTGAGCTT 3’            NcoI  CtsX fusion 5’ 
pRSW254  5’ TCCCCCCGGGCTTTCCATCTAATTCCATTAAACCATA 3’       XmaI  CtsX full fus 3’ 
pRSW255  5’ CTCATCCATGGCGCAAGAAAGAATTAAAGAGCTTGAGCTT 3’     NcoI  CtsX fusion 5’ 
pRSW255  5’ TCCCCCCGGGCTTTCCATCTAATTCCATTAAACCATA 3’       XmaI  CtsX full fus 3’ 
pRSW256  5’ CGCGGATCCCAAGAAAGAATTAAAGAGCTTGAGCTT 3’      BamHI  Cj1472c comp strt 
pRSW256  5’ CCGCTCGAGCTTTCCATCTAATTCCATTAAACCATA 3’      XhoI  Cj1472c no stp cod 
pJMB1       5’ CGCGGATCCAGTAAAATTATTCCCATTTAGAGAAGAA 3’    BamHI  CtsX comp st + 
BamHI 
pJMB1       5’ CCGCTCGAGTTACCTTAATAAGCCATTCTCTAAAGA 3’      XhoI  CtsX comp stop 
+XhoI 
 
 
2.5.3 Construction of Walker Box point mutants 
 Point mutants were constructed in the Walker boxes of ctsE and ctsP by 
PFU mutagenesis (Stratagene).  Both ctsE and ctsP were cloned into pRSW211 
to create C-terminal FLAG fusions, pRSW223 (CtsE-FLAG) and pRSW208 
(CtsP-FLAG). The conserved lysine residue (K296) of the Walker box A of CtsE-
FLAG was mutated by changing the coding sequence from AAA to CAA resulting 
in an amino acid change to a glutamine (K296Q); this plasmid was designated 
pRSW246.  The conserved glutamic acid residue (E81A) of the Walker box B of 
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CtsP-FLAG was mutated by changing the coding sequence from GAA to GCA 
resulting in an amino acid change to an alanine (E81A); this plasmid was 
designated pRSW228. DH5. pRK212.1 was transformed with these constructs 
and conjugations were performed as described previously [236, 239].  pRSW208 
and pRSW228 were conjugated into DRH212  ΔctsP (RSW115), while pRSW223 
and pRSW246 were conjugated into DRH212 ΔctsE (RSW136) [5].  
Transconjugants were verified by PCR.  Expression of the fusion proteins was 
detected in whole cell lysates by SDS-PAGE and western blot analysis as 
discussed below. 
2.5.4 Construction of His fusion proteins 
To express a 6x-His tagged version of CtsX, genomic DNA from C. jejuni 
strain 81-176 was used as a template to amplify ctsX from the second codon to 
the stop codon using a forward primer with a BamHI site and a reverse primer 
with XhoI site flanking the coding sequence. This fragment was cloned into the 
BamHI and XhoI sites of pBW206, a derivative of pECO102 that contains a N-
terminal 6x-His tag immediately upstream of the BamHI site, creating JMB1.  
This plasmid was transformed into DH5 pRK212.1 and transferred by 
conjugation into the ΔctsX strain as described previously [236, 239]. 
Transconjugants were verified by PCR and the stability of the fusion proteins was 
assessed using SDS-PAGE and Western blot analysis from whole cell lysates.  
2.5.5 Transformation assays 
Transformation assays were performed as described previously. [5, 193].  
Briefly, C. jejuni was grown 16 – 18 hours on MH agar plates supplemented with 
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appropriate antibiotics.  Cells were resuspended in MH broth to an optical density 
at 600 nm of 0.5 and 500 l aliquots were added to 13 mm test tubes containing 
one ml solidified agar.  After incubation for three hours at 37°C in 5% CO2, one 
microgram of DRH153 (81-176 astA::aphA3) DNA was added and the cultures 
were incubated for an additional four hours [238].  The number of transformants 
and the total number of bacteria were determined by dilution plating on MH agar 
with appropriate antibiotics.  Transformation efficiency represents the number of 
transformants per total number of bacteria per microgram of DNA.  
Transformations were conducted in triplicate and the transformation efficiency 
represents the average of the three samples from one experiment.   
2.5.6 Cell Fractionations 
 Cell fractionation was carried out as previously described for C. jejuni with 
a few modifications [218].  C. jejuni was cultured on MH agar plates under 
microaerophilic conditions at 37C for 16 – 18 hrs.  Cells were resuspended from 
plates in MH broth and centrifuged (10,000 x g, 10 min at 4C) and the resulting 
pellet was resuspended in 10 mM HEPES pH 7.4.  After one freeze-thaw cycle in 
a dry ice-ethanol bath, cells were sonicated with a micro-tip in a Branson digital 
sonifier at 30% amplitude six times for 10 seconds.  Cell debris was pelleted by 
centrifugation (10,000 x g, 10 min at 4C in a Sorvall tabletop centrifuge) and the 
supernatants were subjected to ultracentrifugation to pellet membranes (100,000 
x g, 70 min at 4C with a SW41 rotor).  The supernatant was removed and saved 
as the soluble fraction; the pellet (membrane fraction) was washed once in 10 
mM HEPES and subsequently resuspended in an appropriate volume of 10 mM 
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Tris-HCl pH 8.0.  The soluble fraction contains cytoplasmic and periplasmic 
contents while the membrane fraction contains both inner and outer membranes.  
The same procedure was followed for fractionation of E. coli.  Protein 
concentrations were determined with the BioRad protein assay or with the 
ThermoScientific BCA assay per manufacturer’s instructions. Equal 
concentrations of proteins were then analyzed by SDS-PAGE and Western blot 
analysis.  
2.5.7 Membrane Flotation 
 C. jejuni was cultured on MH agar plates under microaerophilic conditions 
at 37C for 16 – 18 hrs.  Cells were resuspended from plates in MH broth and 
centrifuged (Sorvall tabletop centrifuge, 10,000 x g, 10 min at 4C) and the 
resulting pellet was resuspended in P Buffer (100 mM sodium phosphate pH 7.6, 
50 mM MgCl2, and 10 mM EDTA). Cells were lysed by passage through a French 
press. Lysates were incubated with DNase for 30 minutes and centrifuged (5000 
rpm for 5 min at 4C) to remove cell debris. The supernatant was subjected to 
ultracentrifugation (100,000 x g, 1 hour, at 4C, SW41 rotor), and a sample of the 
supernatant, containing the cytosolic and periplasmic proteins, was collected. 
The pellet was resuspended in P buffer and centrifuged (100,000 x g, 1 hour, at 
4C, SW41 rotor).  The supernatant was discarded and the pellet was 
resuspended in P buffer and mixed with 81% sucrose (dissolved in P buffer) to a 
final concentration of 71%. The sample was overlaid with 52% and 42% sucrose 
and subjected to ultracentrifugation (18 hour at 100,000 x g, at 4C, SW41 rotor). 
After ultracentrifugation, the presence of the membrane bands was noted. 
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Fractions (1.8 ml) were taken, starting from the top of the sample and labeled 1-6 
sequentially. The sucrose was diluted in P buffer and proteins were precipitated 
using 2% deoxycholate and trichloroacetic acid (TCA) overnight at 4C. After 
precipitating the proteins, fractions were subjected to ultracentrifugation (1.5 
hour, at 100,000 x g, at 4C, SW41 rotor). Pellets from each fraction were 
washed with acetone to remove residual TCA and subsequently with 100% ether 
to remove lipids. Pellets were vacuum dried and resuspended in water to be 
tested in the isocitrate dehydrogenase assay or resuspended in 6X sample buffer 
for SDS-PAGE and immunoblot analysis. 
2.5.8 SDS-PAGE and Immunoblotting 
 To detect FLAG fusion proteins, samples were diluted 1:1 with 2X SDS 
sample buffer and boiled for five minutes before loading onto 12% 
polyacrylamide gels for separation by SDS-PAGE.  For His-CtsX containing 
samples, samples were diluted 1:6 with 6X SDS sample buffer and were 
separated on a 15% polyacrylamide gel. Samples were normalized by protein 
concentration.  Proteins were transferred to nitrocellulose membranes (Hoefer 
semi-dry, 200 mAmps for 2 hours) and, after blocking with 5% milk in TBS, 
membranes were probed with primary antibody.  For FLAG-tagged fusion 
proteins, an anti-FLAG M2 monoclonal antibody peroxidase conjugate (Sigma) at 
1:1000 was used. This was developed using the Western Lighting 
Chemiluminescence reagent plus (Perkin-Elmer Life Sciences).  For the His-
tagged fusion protein, THE™ His-tag antibody (Genscript) at 1:1500 was used. A 
rat anti-mouse IgG1-HRP conjugated antibody (Southern Biotech) was used at 
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1:3500 for the secondary antibody and blots were developed using SuperSignal 
West Pico Chemiluminescent Substrate (ThermoScientific).  
2.5.9 Isocitrate Dehydrogenase assays 
 To demonstrate efficient fractionation, fractions were tested for the 
presence of isocitrate dehydrogenase, a cytoplasmic protein.  Isocitrate 
dehydrogenase activity was assayed as described previously [218].  The reaction 
mixture contained 100 l 10 mM MgCl2, 100 l 50 mM Tris-HCl pH 8.0, 100 l 10 
mM NADP, 550 - 600 l distilled H2O, and 0 – 50 l of the cell fraction.  The 
reaction was started by the addition of 100 l of 50 mM sodium isocitrate and the 
optical density at 340 nm was read at 15 second intervals for three minutes.  The 
specific activity of isocitrate dehydrogenase was calculated using an absorption 
coefficient of NADPH of 6.22 mM-1 cm-1 at 340 nm.  The percent (of total 
unfractionated sample) of isocitrate dehydrogenase activity present in each 
fraction was calculated.  For all fractionations, a minimum of 90% of the isocitrate 
dehydrogenase activity was present in the cytoplasmic fraction. 
2.5.10 Identification of interacting proteins with the bacterial-two hybrid 
system 
 A bacterial two hybrid system was used to identify potential interactions 
among Cts proteins.  This system is based on functional complementation 
between two fragments of the catalytic domain of adenylate cyclase from 
Bordetella pertussis [219].  Genes ctsE, ctsP, ctsX, ctsF, ctsD, ctsR, ctsG, ctsW, 
and dprA were PCR amplified from the coding sequence of the second amino 
acid through the stop codon and cloned into the PstI and BamHI sites of pT25 to 
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generate in-frame T25 fusion proteins.  The same genes were amplified with 
primers containing XhoI and ClaI sites from the second amino acid to the last 
amino acid, excluding the stop codon, and inserted into the XhoI and ClaI sites of 
pT18 to create in-frame fusion proteins to the adenylate cyclase T18 domain.  
The insertions in these plasmids were verified by PCR and confirmed by 
sequencing. 
 E. coli strain Sp850 (cya-) was transformed with all combinations of Cts-
pT18 and Cts-pT25 plasmids and transformants were screened for protein-
protein interactions by growth on LB agar plates at 30C with 100 g ml-1 
ampicillin, 30 g ml-1 chloramphenicol, 40 g ml-1 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal), and  0.5 mM isopropyl-β-D-thiogalactopyranoside 
(ITPG).  The negative control contained Sp850 with pT18 and pT25 and the 
positive control was Sp850 with pT18-Zip and pT25-Zip [219]. Assays were done 
in triplicate and the data represent the average of three biological replicates.  
Standard deviation is indicated. 
2.5.11 Topology analysis of CtsX   
 LacZ and PhoA Fusions of ctsX were made using pTrcLacZ and 
pTrcPhoA [223].  Translational fusions were generated at amino acid residues 
14, 50, and 89 and 195 (the final amino acid in full length CtsX protein).  These 
sites were chosen after analysis of CtsX hydrophobicity by several computer 
programs (Kyte Doolittle, EMBL) which predicted a transmembrane segment at 
roughly amino acids 22 – 42.  PCR products were cloned into the NcoI and XmaI 
sites in pTrcLacZ and pTrcPhoA.  Plasmids were screened by PCR and verified 
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by sequencing.   E. coli strain TG1 was transformed with these plasmids to carry 
out alkaline phosphatase assays and β-galactosidase assays using standard 
methods [222].  Strains were assayed in triplicate and the data represent the 
average of three biological replicates.  Standard deviations are indicated.   
2.5.12 Membrane extractability of CtsP and CtsX fusion proteins  
 For membrane solubility studies, cells were fractionated as described 
previously. Purified membranes were diluted 1:1 into either a) 10 mM Tris-HCl 
pH 8.0, b) 1 M NaCl, c) 2 M NaCl, d) 3 M urea, e) 5 M urea, f)  0.5 M Na2CO3 pH 
3.0, g) 0.5 M Na2CO3 pH 11.0 or h) 1 M KCl. and rocked on a nutator mixer for 30 
minutes at 4C.  Membranes were subsequently collected by ultracentrifugation 
(1 hour, 100,000 x g, at 4C, SW41 rotor) and were resuspended in 50 l of 10 
mM Tris, pH 8.0.  The supernatant was removed and precipitated by addition of 
400 l of acetone, incubation at -20C for one hour, and centrifugation at 16,000 
x g at 4C.  Precipitated proteins were air dried for 30 minutes and resuspended 
in 50 l of 10 mM Tris-HCl pH 8.0.  Equal volumes of soluble and membrane 
fractions were resuspended in SDS sample buffer and loaded onto 
polyacrylamide gels for separation by SDS-PAGE and Western blot analysis to 
detect CtsX or CtsP as described above. 
2.6 Notes 
This work was in colloraboration with Dr. Rebecca Erfut and has been published 
and can be cited as follows: 
Beauchamp, J. M., R. S. Erfurt and V. J. DiRita (2015). "Characterization and 
localization of the Campylobacter jejuni transformation system proteins CtsE, 
CtsP, and CtsX." J Bacteriol 197(3): 636-645. 
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CHAPTER III 
 
IDENTIFICATION OF METHYLATION DEPENDENT DNA SELECTION IN 
CAMPYLOBACTER JEJUNI NATURAL TRANSFORMATION 
 
3.1 Abstract 
Campylobacter jejuni, a leading cause of bacterial gastroenteritis in the 
developed world, is one of approximately sixty-five identified naturally competent 
bacteria.  This trait may contribute to the large amount of diversity seen between 
sequenced strains of C. jejuni. The mechanisms underlying how DNA is 
recognized for uptake and recombination are not well characterized in C. jejuni.    
Although C. jejuni can readily be transformed by C. jejuni derived DNA, it is 
poorly transformed by the same DNA derived from E. coli or via PCR.   Our work 
indicates that methylation plays an important role in marking C. jejuni 
transforming DNA.   DNA derived from a mutant lacking a specific DNA 
methyltransferase, which we term Campylobacter transformation system 
methyltransferase (ctsM) transforms wild type C. jejuni at levels several orders of 
magnitude lower than DNA containing the CtsM mark.  Both ctsM mutant and 
wild type become transformed to the same levels when provided DNA from wild 
type (CtsM+).  The ctsM mutant cannot be transformed by its own DNA, i.e. DNA 
lacking the specific methylation. However, it otherwise grows like wild type, with 
no evidence of its own DNA being restricted due to loss of the methyltransferase. 
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We confirmed that the DNA purified from the ctsM mutant lacks methylation at 
the methyltransferase recognition site RAATTY.  These data indicate that the 
presence of the methyl mark at this site enhances transformability of the DNA. 
This extends to DNA derived from E. coli DNA and methylated in vitro at 
RAATTY; the in vitro methylated DNA is sufficient to transform C. jejuni whereas 
otherwise identical unmethylated DNA is not.  We also demonstrate that only one 
methylated site is required to allow for transformation.  We also determine that 
selection occurs inside the cell, not at the outer membrane. Here we demonstrate 
a mechanism of DNA selection in C. jejuni that is distinct from DNA selection by 
other competent bacteria.  
3.2 Introduction 
Natural transformation, the ability of bacterial cells using dedicated 
machinery to transport DNA into the cytosol and recombine it into the genome, is 
a widespread trait. As a mechanism of horizontal gene transfer, it may allow 
bacteria to acquire new genes to better adapt to their environment. Over 65 
species of both Gram negative and Gram positive bacteria are naturally 
competent, expressing protein complexes that span all cellular compartments to 
acquire exogenous DNA and transport it into the cell for recombination with the 
chromosome [27].    
One such bacterium is Campylobacter jejuni, a leading cause of bacterial 
gastroenteritis worldwide. C. jejuni often colonizes the avian intestinal tract; a 
common source of infection is consumption of contaminated poultry [198]. The 
ability to readily acquire DNA from the environment may contribute to the 
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extensive genetic diversity observed among strains of C. jejuni. Horizontal gene 
transfer in vivo has been demonstrated during experimental infection of chicks, a 
natural host for this pathogen [3]. 
C. jejuni is exceedingly selective in the DNA it uses for natural 
transformation, using DNA originating from  closely related strains. Many bacteria 
actively select the DNA used for transformation. One such mechanism for 
selection involves the use of  DNA uptake sequences (DUS) [119, 120, 240]. 
These are sequences of ten to twelve base pairs repeated frequently throughout 
the genome. Uptake sequences have not been identified in Campylobacter. 
Evidence indicates that DNA selection does not appear to be solely sequence-
based because a given piece of DNA transforms C. jejuni when the DNA is 
isolated from C. jejuni but not from E. coli [193].     
DNA methyltransferases (MTases) play many roles in biology; a key one 
in bacteria is to identify foreign DNA through restriction modification systems (RM 
systems). RM systems expressed in many different bacteria protect from phage 
attack.  DNA MTases methylate specific sequences of bacterial DNA to protect 
the DNA from restriction enzyme (REase) degradation.  Incoming phage DNA 
lacks the methylation pattern of its host.   Cognate REases therefore degrade 
phage DNA without affecting the methylated bacterial DNA.  These RM systems 
play a role in transformation in Helicobacter pylori, a close relative of C. jejuni.  
The HpyAXII RM system degrades unmethylated plasmid and chromosomal 
DNA during natural transformation [112].  Other RM systems degrade incoming 
DNA lacking the proper methylation motifs as well as decreasing the length of 
 82 
 
integrated DNA [113, 114]. Similarly, increasing numbers of NlaIV restriction sites 
has an inhibitory effect on transformation in Neisseria meningitidis [116]. A 
negative correlation between the RM systems and transformation has also been 
demonstrated in Pseudomonas stutzeri [115]. In all of these cases, incoming 
DNA lacking the appropriate methylation motifs is then degraded and therefore 
cannot complete the transformation process by recombining onto the 
chromosome. In C. jejuni strain 11168, the RM system encoded by Cj1051c, 
plays a role in DNA selection of plasmid DNA [194]. When this system is deleted, 
transformation of plasmids derived from other Campylobacter strains is 
enhanced [194].  However, strains lacking this system are still unable to be 
transformed by E. coli derived plasmids [194]. While this system is important in 
strain 11168, it is not widely distributed throughout Campylobacter strains nor 
does it completely explain the DNA discrimination observed as E. coli derived 
plasmids are still non-transformable. Therefore, it cannot be the sole determinant 
of DNA selection in C. jejuni.  
A large number of DNA MTases have been identified among the 
numerous sequenced C. jejuni strains.  These DNA MTases tend to differ among 
strains. Using Single-Molecule Real-Time (SMRT) sequencing, active DNA 
MTases and the sequences they methylate were identified [144, 149-153].  We 
chose to examine the role of the single conserved methylation motif RAm6ATTY 
in the laboratory strain DRH212, a streptomycin resistant derivative of 81-176.  
We hypothesized that recognition of methylation of this motif would allow 
Campylobacter to distinguish DNA from close relatives from DNA from other 
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species, as the methylated motif has been found in all Campylobacter SMRT 
sequenced strains to date. This methylation mark is conferred by a single DNA 
MTase, Cjj81-176_0240, conserved in Campylobacter species but not in other 
closely related genera. It lacks a cognate restriction enzyme, putting it into the 
class of orphan methyltransferases, similar to the dam enzyme of E. coli and 
others.  We hypothesized this MTase is important for DNA selection in natural 
transformation.   
This study demonstrates that the motif, RAm6ATTY functions as an uptake 
sequence in C. jejuni. DNA lacking methylation at this motif transforms C. jejuni 
at levels orders of magnitude lower than DNA carrying the methyl mark.  We term 
this orphan methyltransferase (Cj81-176_0240)  Campylobacter transformation 
system methyltransferase, ctsM.   CtsM methylated DNA or DNA methylated in 
vitro to introduce the RAATTY site is required for transformation into C. jejuni. 
Methylation of this motif enables E. coli or PCR-derived DNA to serve as a high-
efficiency substrate for transformation in comparison to similar DNA lacking the 
RAATTY methylation mark.  Furthermore, DNA localization studies suggest that 
the selection for methylated DNA occurs inside the cell.  
3.3 Results 
3.3.1 One methylation motif is conserved among all SMRT sequenced 
strains of Campylobacter.  
Campylobacter species have a large number of annotated DNA MTases 
[160].  Introduction of SMRT sequencing has enabled easy identification of all 
adenosine methylation motifs as well as some cytosine methylation motifs [144].  
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These methylation motifs can be paired with their corresponding MTase genes 
using both bioinformatics and genetic mechanisms.  To date ten Campylobacter 
strains have been sequenced using this method, including four C. jejuni isolates 
[149-153]. These strains include laboratory, animal, and human isolates (Table 
3.1). Of the thirty-four methylation motifs identified, only one methylation motif 
and cognate DNA MTase was conserved among all ten of these strains.  Five 
methylation motifs were found in more than one strain, but the majority of 
methylation motifs were only found in one strain. The diversity of methylation 
patterns indicates that even though two strains might be closely related, their 
DNA will have different patterns of methylation.  
The single conserved methylation motif is RAm6ATTY.  Not only is this 
methylation motif found in all SMRT sequenced strains of Campylobacter, it is 
over-represented in the C. jejuni genome (Fig 3.1).  Of the 26,876 RAATTY sites 
in the genome, 26,609 sites were found to be methylated [149]. Because C. 
jejuni has a small genome, on average this results in a RAATTY motif 
approximately every sixty base pairs, nearly 70 times more frequent than is 
predicted for a six-base motif. This is significantly more than the other 
methylation motifs identified or for another six base pair recognition sequence, 
GKAAYG, for which 1,236 or 1,259 sites were methylated (Fig 3.1) [149]. We 
hypothesized that recognition of methylation of this methylation motif, which has 
been found in all SMRT sequenced Campylobacter strains to date, would allow 
Campylobacter to identify DNA from close relatives from other species for use in 
transformation.  
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In 81-176, this methylation mark is conferred by CJJ81176_0240, which 
we term Campylobacter transformation system methyltransferase, ctsM [149]. 
This D12 class N6 adenine specific DNA MTase is an orphan MTase, meaning it 
has no cognate restriction enzyme.  Using a BLAST search, we determined that 
this gene is highly conserved among Campylobacter species but has a more 
limited conservation outside this genus.  We hypothesized that this particular 
MTase would play a role in DNA selection during transformation for two reasons.  
First, its high degree of conservation within Campylobacter indicates an 
important role in a variety of habitats (it is active in laboratory, human and animal 
isolates), while its lack of conservation outside the genus suggests it might help 
discriminate Campylobacter DNA from non-Campylobacter DNA.  Second, its 
lack of a cognate restriction enzyme as an orphan DNA MTase indicates that it 
might play a unique role in the biology of this bacterium outside of restriction-
modification per se.  
 
Recognition 
Sequence 
Laboratory Strains 
Human 
Isolate 
Sheep 
Isolate 
C. coli 
C. 
peloridi
s 
C. subantarcticus 
UPTC 
NCTC 
Campyl
obacter 
spp. 
81-176  
[149] 
11168 
[149] 
F3801
1 [150] 
IA3902 
[153] 
BfR-
CA-
9557 
[151] [152] 
LMB 
24374 
[152] 
LMG 
24377 
[152] 
11845   
[152] 
RM167
04 
[152] 
RAATTY + + + + + + + + + + 
GATC - - - - + + + + + - 
TAAYN5TGC + + - + +/- - - - - - 
CAAGAA - - - - + + - - - - 
GCAAGG + +/- +/- + - - - - - - 
GAGN5GT - + - +/- - - - - - - 
CAAYN6ACT + - - - - - - - - - 
GGRCA + - - - - - - - - - 
GAGN5RTG - - + - - - - - - - 
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AN4CGNAAAT
TY 
- - + - - - - - - - 
CTAN8TAYC - - + - - - - - - - 
GAAGAA - - - + - - - - - - 
RCATC - - - - + - - - - - 
GGGTDA - - - - + - - - - - 
DACATTGB - - - - + - - - - - 
TAAAN5TTTA* - - - - + - - - - - 
CACN5TTTA* - - - - + - - - - - 
CAAYN7TTYG
# 
- - - - + - - - - - 
CRAAN7RTTG
# 
- - - - + - - - - - 
GGRAT - - - - - + - - - - 
TAAYN6RTTG - - - - - + - - - - 
ACCTA $ - - - - - + - - - - 
ATCN7TCC - - - - - - + - - - 
GAYN7TYTC - - - - - - + - - - 
GNCGAA - - - - - - + - - - 
AACCA - - - - - - + - - - 
GGAAY $ - - - - - - + - - - 
GAGG - - - - - - - + - - 
GTRGAG - - - - - - - + - - 
CCAAT - - - - - - - + - - 
GWCAT - - - - - - - + - - 
GCGAA - - - - - - - - + - 
CAYN6RTG - - - - - - - - + - 
GANTC - - - - - - - - - + 
GCATC - - - - - - - - - + 
CGAN8ACA - - - - - - - - - + 
 
Table 3.1: Identified methylation motifs in Campylobacter strains.  Methylation 
motifs were determined using SMRT sequencing.  Ambiguous nucleotides are denoted 
using IUPAC ambiguity codes. +/- indicates the motif contains one nucleotide difference 
between the two strains.  Underlining indicates the methylated base. Stars (*) and pound 
signs (#) indicate double stranded motifs where the methylation occurs in different spots 
on each strand. Dollar signs ($) indicate approximately 50% of DNA was methylated. 
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Figure 3.1 Distribution of all possible methylation motifs in 81-176.  CtsM 
(RAATTY) sites are indicated in green. For comparison, EcoRI (GAATTC) sites 
are in red.  M.  CjeFII (CAAYN6ACT) sites are in dark blue, M. CjeFIII (GCAAGG) 
sites are in black, M. CjeFIV (TAAYN5TGC) are in light blue, and M. CjeFV 
(GGRCA) sites are in fuschia.  
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To test the role of ctsM in transformation, we constructed an insertion-
deletion allele and assayed for loss of methylation by testing the sensitivity of 
DNA from the mutant strain to restriction by EcoRI or ApoI. The recognition site 
of each enzyme overlaps the RAm6ATTY site predicted to be the substrate of 
CtsM, and neither can cleave DNA when that site is methylated.  DNA from the 
mutant strain could be digested by both EcoRI and ApoI, whereas DNA from the 
wild type strain could not. (Fig 3.2).  
  
Figure 3.2 DNA from ctsM::kan is degraded by ApoI and EcoRI. gDNA was 
purified from either DRH153 cells or ctsM::kan mutants.  The DNA was then 
either mock digested (lanes 1 and 2) or digested (lanes 3 and 4) with the 
restriction enzymes EcoRI (left) or ApoI (right). The DNA was then 
electrophoresed  on an agarose gel and visualized using ethidium bromide. 
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3.3.2 Loss of RAm6ATTY methylation negatively affects transformation 
Having confirmed that DNA methylation was disrupted in ctsM::kan, we 
tested whether the methylation at RAATTY is required for transformation.  gDNA 
was purified from a strain carrying a marker for kanamycin resistance in the astA 
gene or from the ctsM::kan mutant strain.  Both were used in separate 
transformation assays to transform our wild type strain DRH212. The mutant 
gDNA lacking methylation at the RAATTY site transformed to levels 
approximately 10,000 times lower than gDNA cells wild type for ctsM, indicating 
that the RAm6ATTY methylation mark is critical for the ability of gDNA to serve as 
a substrate in transformation (Fig 3.3).   
 
Figure 3.3 DNA lacking CtsM methylation is a poor substrate for 
transformation. DNA was purified from either DRH153 or the ctsM::kan mutant.  
This DNA was then used to transform DRH212 cells.  Transformation efficiency 
was calculated as described in the Materials and Methods section. Results are 
from three biological replicates and each biological replicate included three 
technical replicates. Errors bars indicate standard deviation. 
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We then tested the ability of the ctsM mutant strain to be transformed, 
using gDNA from cells containing different antibiotic resistance marker cassettes 
or alleles (kanamycin and chloramphenicol cassettes at the astA locus, or a 
gyrA256 allele encoding resistance to naladixic acid).  Purified gDNA from these 
different antibiotic resistance mutants was used in transformation assays with 
wild type and ctsM mutant C. jejuni.   No difference in transformation frequency 
was detected using these gDNAs as substrates (Fig 3.4A), indicating that the 
MTase does not affect the ability of the cell to be transformed, just the ability of 
DNA to act as a substrate in transformation.   The ctsM mutants were unable to 
be transformed with their own gDNA, i.e. DNA lacking the methylation at 
RAATTY, similar to wild type cells (Fig 3.4B), indicating that as in wild type cells, 
those lacking CtsM require the incoming DNA to be methylated at the RAATTY 
site for natural transformation 
Collectively our data suggest that the ctsM is required for methylation at 
the RAATTY site, and, while not required for cells to be competent for 
transformation, is required for DNA to serve as a substrate for transformation.   
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Figure 3.4 ctsM mutants are transformed with WT frequency by WT gDNA 
but not their own gDNA A) WT DNA with three distinct antibiotic resistance 
markers (kanamycin, chloramphenicol, and naladixic acid) was purified and used 
to transform DRH212, ctsM::kan, or ctsM::cm cells.  Transformation efficiency 
was calculated as previously described.  n.d. indicates that transformation 
efficiency was not determined because the cells already contained the antibiotic 
resistance being used to transform cells.  B) DRH154 cells or ctsM::cm cells 
were transformed with either DRH153 gDNA or DNA from the ctsM::kan gDNA 
and transformation efficiency was measured as previously described.  Data 
represents three biological replicates.  Each biological replicate contained three 
technical replicates.  Errors bars indicate standard deviation. 
 
 
3.3.3 Methylation at RAATTY is required for transformation 
The ctsM mutant strain produces gDNA that i) that serves as a poor 
substrate for natural transformation and ii) is more readily digested by enzymes 
(EcoRI and ApoI) that are inhibited by methylation at the site recognized by this 
methyltransferase. To test directly whether the methylation mark provided by 
CtsM is required for transformation, we took advantage of the fact that EcoRI 
MTase (M. EcoRI) recognizes the same a subset of RAATTY sites, GAATTC. 
Commercially obtained M. EcoRI was used to methylate gDNA from the 
ctsM::kan strain.  As controls, we used two other commercially available MTases, 
M. TaqI and M. HpaII, which methylate the sites TCGm6A and Cm6CGG 
respectively.  
After treatment with the MTases, purified gDNA from ctsM::kan was 
protected from digestion by each cognate restriction enzyme, confirming the 
gDNA had been successfully methylated.  We then measured the transformation 
efficiency of C. jejuni when provided these methylated gDNAs as substrates, in 
comparison to transformation with wild type gDNA (Fig 3.5).  The gDNA that was 
methylated by M. EcoRI transformed as well as gDNA from wild type C. jejuni, 
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with a frequency approximately 1000 times higher than gDNA from the ctsM 
mutant that had not been methylated by M.EcoRI, or that was methylated by M. 
TaqI or M. HpaII.  
These results indicate that methylation of the RAATTY site is required for 
transformation. Further, while the M. EcoRI site overlaps with and methylates the 
same site as CtsM, the site is more specific (GAATTC versus RAATTY) than the 
site recognized by the Campylobacter enzyme.  Given that fewer overall sites will 
be methylated by M. EcoRI than by CtsM, our data also suggest that not every 
RAm6ATTY site needs to be methylated for transformation to occur.  
 
Figure 3.5 In vitro methylation at the CtsM site RAATTY but not at other 
sites significantly enhances gDNA substrate capability. DNA was purified 
from either DRH153 or ctsM::kan cells.  ctsM::kan DNA was then either mock 
methylated or in vitro methylated with EcoRI MTase, TaqI MTase, or HpaII 
MTase.  EcoRI MTase methylated GAm6ATTC; TaqI methylates TCG m6A; and 
HpaII methylates C m6CGG. DRH212 cells were transformed with the methylated 
DNA.  Transformation efficiency was calculated as previously described.  Data 
represents three biological replicates.  Each biological replicate contained three 
technical replicates.  Errors bars indicate standard deviation. 
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3.3.4 In vitro methylation by M. EcoRI is sufficient to allow E. coli derived 
plasmids and PCR generated products to transform Campylobacter 
Relative to gDNA purified from wild type C. jejuni, DNA from lab strains of 
E. coli or derived in vitro by polymerase chain reactions (PCR) is a poor 
substrate for Campylobacter transformation.  The mechanism for this selection 
has been unclear.  As we had shown that methylation of RAATTY was necessary 
for transformation, we next wanted to determine whether this methylation is also 
sufficient for transformation.   
We constructed antibiotic cassettes flanked with the C. jejuni astA 
sequence in order to allow for homologous recombination; these were cloned into 
pUC19, which is unable to replicate in C. jejuni.  The resulting plasmids have 
three EcoRI sites, two in astA and one in the pUC19 vector (Fig 3.6A).  We 
purified these plasmids from E. coli, methylated them with M. EcoRI, confirmed 
their methylation using restriction digest, and assessed their ability to transform 
DRH212 by selecting for the antibiotic cassette (Fig 3.6B).  Plasmids treated with 
M.EcoRI transformed C. jejuni at frequencies similar to gDNA, and at frequencies 
1000 times greater than unmethylated DNA of the same origin.    
We also tested the ability of methylated PCR products to transform C. 
jejuni. We designed primers to amplify two different PCR products from the 
plasmids described above.  The first contains the homologous DNA and the 
kanamycin cassette (astAkan), and has two closely spaced EcoRI sites in the 
astA sequence (Fig 3.6A).  The second is larger and has a third EcoRI site 
derived from the multiple cloning site of the pUC19 backbone (Fig 3.6A). These 
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fragments were amplified and methylated with M. EcoRI.   After confirming 
methylation using restriction digests we tested if they could serve as efficient 
DNA transformation substrates for DRH212 (Fig 3.6C). Both products 
transformed DRH212 at frequencies much higher than their non-methylated 
cognate fragments.  The larger product, containing three EcoRI sites, 
transformed about 10 times better than the smaller product with only two sites.  
This is most  likely due to the increased amount of homologous DNA contained in 
the larger fragment, which has been demonstrated to greatly increase 
transformation frequency in V. cholerae (Ankur Dalia, personal communication).   
 
Figure 3.6 In vitro methylation by M.EcoRI allows for transformation of plasmid 
and PCR products. A) Plasmid map of pJMB202 with pertinent features denoted.  KanR 
refers to a kanamycin resistance cassette. It is inserted in astA. Small arrows refer to 
primer pairs. These were used to amplify the PCR products astAkan and M13 indicated 
in green and purple rectangles respectively, used in Part C. pJMB203 is identical except 
contains a chloramphenicol resistance gene insertion instead of a kanamycin resistance 
gene insertion. B) DRH212 cells were transformed with various types of DNA as 
indicated. C) PCR products were created by amplifying a fragment from as indicated.  
These products were then methylated in vitro using EcoRI MTase.  These DNA 
fragments were then used to transform DRH212 cells. Transformation efficiency was 
calculated as previously described.  Data represents three biological replicates.  Each 
biological replicate contained three technical replicates.  Errors bars indicate standard 
deviation. 
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3.3.5 One methylated RAATTY site is sufficient for transformation 
In order to determine the exact requirements for transformation, we 
performed site directed mutagenesis on pJMB203 to generate plasmids 
pJMB204-209, either adding (JMB204) or eliminating (JMB205-209) EcoRI sites 
(Fig 3.7A).  This allowed us to determine the number of methylated RAATTY 
sites required for transformation as well as the location of the sites relative to the 
recombining DNA.  We determined that one site is sufficient to allow for 
transformation and that the site does not need to be located on the DNA that will 
ultimately recombine (Fig 3.7B). The site can be at least one kilobase away 
without significantly impacting transformation efficiency.  
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Figure 3.7 One methylated EcoRI site is sufficient for transformation. A. 
Diagram of plasmids used. EcoRI sites (E) are in red. The exact sites of the EcoRI sites 
are indicated for pJMB204. The plasmids are identical except for the location and 
number of EcoRI sites.  B. DRH212 cells were transformed with different plasmids as 
indicated and transformation efficiency was measured as noted previously.  Errors bars 
indicate standard deviation. 
 
  
3.3.6 DNA lacking RAATTY methylation is internalized 
Having identified that methylation at RAATTY is necessary and sufficient 
for transformation, we wanted to determine when during transformation 
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methylated DNA is selected.  To determine this, we performed a DNA binding 
and uptake assay. This assay differentiates DNA that has been internalized by 
the cell (become DNase resistant) from cell associated DNA (DNA that has either 
been bound on the surface of the cell or has been internalized).   
  We sought to determine if the mechanism by which methylated versus 
unmethylated is recognized for transformation includes binding of the methylated 
DNA to the surface of the cell prior to being taken up.  We carried out DNA 
binding and uptake assays as describe in Materials and Methods.  We observed 
equivalent amounts of DNA from wild type and DNA from ctsM::kan becoming 
DNase resistant indicating that lack of methylation does not preclude DNA from 
becoming internalized (Fig 3.8).  
 
Figure 3.8 DNA lacking RAATTY methylation becomes internalized. DRH212 
cells were incubated with either DRH53 (kanR) or ctsM::kan DNA for one hour.  
They were centrifuged, washed, split and either mock treated or treated with 
DNase. Mock treated cells contain the cell associated DNA (yellow) and DNase 
treated cells have internalized DNA (blue). After DNase incubation, cells were 
washed and DNA was purified.  The DNA was quantified via qPCR using primers 
to the kanamycin cassette.  Total DNA was also quantified and the amount of 
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DNA was normalized to total DNA. Data represent four biological replicates. 
Each biological replicate contained three technical replicates. Errors bars indicate 
standard error. 
 
 
3.4 Discussion 
The goal of this study was to understand how C. jejuni selects DNA during 
natural transformation.  We identified a methylation motif, RAm6ATTY, which 
plays a critical role in the mechanism by which selection takes place. When this 
site is methylated, the DNA will transform cells at a much higher frequency than 
when the DNA is not methylated.  The 26,609 methylated RAATTY sites are 
distributed fairly equally around the genome with the exception of three places 
where there are significantly fewer sites (Fig 3.1). These sites map to the 
ribosomal gene cluster.  81-176 has three copies of this gene cluster and each 5 
kb cluster contains only five RAATTY sites compared to the average of 40 sites 
in the 5 kb flanking each cluster.  This dearth of methylation might affect the 
ability of the sites to be exchanged during natural transformation or might affect 
regulation of these genes.  
Not all of the sites need to be methylated in order for the DNA to be a 
substrate for transformation.  This was demonstrated using in vitro methylation 
using the EcoRI MTase which methylates the more specific, and therefore less 
frequent, site GAATTC.  Furthermore, DNA that was previously untransformable 
such as E. coli derived DNA or PCR generated DNA can be in vitro methylated 
using this MTase and then successfully transform C. jejuni. The PCR products 
contain no other methylation, so this single methylation motif is sufficient for 
 99 
 
transformation.  Using identically sized  plasmids containing different numbers of 
EcoRI sites, we showed that that one methylated EcoRI site, anywhere on the 
plasmid was sufficient for transformation. This argues strongly against a 
restriction based system because both the plasmids and the PCR products 
contained unmethylated RAATTY sites that would be targeted by a restriction 
enzyme.    
This is the first identification of methylation-dependent DNA selection 
process during natural transformation.  This selection process is distinct from 
bacteria such as H. pylori, N. meningitidis, and P. stutzeri which use RM systems 
to degrade DNA that lacks the correct methylation motif [112-116].  CtsM is an 
orphan MTase lacking a cognate restriction enzyme.  Furthermore, insertional 
inactivate of this gene did not which would not be possible if there were an 
unidentified restriction enzyme. This enzyme would degrade the chromosomal 
DNA that was lacking the correct methylation, resulting in cell death. Also, we 
were able to use plasmid DNA that contained seven unmethylated RAATTY sites 
to transform the cells.  If a restriction enzyme existed, it would degrade the 
plasmid at these sites, eliminating transformation. 
While we were unable to determine the precise mechanism for C. jejuni 
recognition of the DNA that it uses in transformation, we were able to provide 
evidence that selection occurs once the DNA is inside the cell as DNA lacking 
RAATTY methylation and fully methylated gDNA became equally DNase 
resistant.  These data lead to three hypotheses the mechanism of DNA selection. 
1) Selection occurs in the periplasm before the DNA is transported into the 
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cytosol. 2) Transportation into the cytosol is dependent on methylation. 3) 
Recombination is dependent on this methylation motif.  
In addition to identifying the DNA selection motif and opening up questions 
about the mechanism through which C. jejuni recognizes this methyl mark for 
transformation, we have provided a potentially powerful tool for genome editing in 
C. jejuni. To introduce DNA into C. jejuni, it is only necessary to methylate it in 
vitro with M. EcoRI, and then successfully transform C. jejuni. This may enable 
transformation of E. coli plasmids or PCR products to make mutations on the 
chromosome  However we were able to transform WT C. jejuni with both plasmid 
and PCR derived DNA after methylation.   
Cells lacking CtsM transform as well, if not better, than WT cells.  This 
DNA MTase and its cognate methylation motif are conserved among the PacBIo 
sequenced Campylobacter strains.  These strains are diverse and range from 
laboratory C. jejuni isolates to the more distantly related C. subantarcticus and C. 
peloridis isolates.  Of more than thirty-five identified methylation motifs, this was 
the only methylation motif that is conserved among all SMRT sequenced strains 
thus far.  If this is the sole selection requirement for DNA in Campylobacter 
competence, we would predict that this methylation motif will be found in all 
naturally competent strains of Campylobacter in order to allow the strain to be 
transformed with its own DNA.  As we were able to insertionally inactivate the 
DNA MTase, it cannot be required for growth in vitro, though its strict 
conservation throughout the genera indicates it might play other roles.   
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Orphan MTases have been a growing field of study and are now 
recognized to play diverse roles in gene regulation. For example Dam MTases 
found in Gammaproteobacteria regulate the timing DNA replication and CcrM 
MTases found in Alphaproteobacteria regulate cell cycle progression [163-166, 
170-172]. Because orphan MTases are more conserved at the genus, family, and 
class level than MTases in RM systems, it is hypothesized that they have a 
functional role distinct from host genome protection [147].  Among over 230 
diverse bacteria, the largest novel class of orphan MTases was those that 
methylated RAATTY [147].  These orphan MTases are found in Campylobacter, 
Akkermanisia muciniphilia, three Spirochaeta species, and three Treponema 
species [147]. In Spirochaeta smaragdinae, RAATTY sites preceded 
transcriptional regulators and were not methylated leading to the suggestion that 
that these orphan MTases play a role in gene regulation [147]. Hypomethylation 
of RAATTY was also identified in C. jejuni in front of rRNAs as well as the 
flagellar genes FlgK and a flagellar basal-body rod protein [153].  
In conclusion, we have identified a novel methylation-dependent DNA 
selection mechanism in C. jejuni. RAATTY methylation is required to allow for 
transformation and when this site is methylated, previously non-transformable 
substrates become capable of transforming C. jejuni.  
3.5 Materials and Methods 
 
3.5.1 Bacterial strains and media 
Bacterial strains used in this work are listed in Table 3.2.  C. jejuni was 
routinely cultured on Muller Hinton (MH) agar with 10% sheep’s blood in 
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microaerophilic conditions (5% CO2, 10% O2, balanced with N2) in a tri-gas 
incubator at 42°C.  When necessary, media was supplemented with antibiotics in 
the following concentrations: trimethoprim (10 µg ml-1), kanamycin (150 µg ml-1), 
naladixic acid (30 ug ml-1 ) and chloramphenicol (15 µg ml-1).  All C. jejuni strains 
were stored at -80°C in MH broth with 20% glycerol. 
Escherichia coli strains were routinely cultured at 37°C in Luria-Bertani 
(LB) broth or agar.  When necessary, antibiotics were used at the following 
concentrations: ampicillin (100 µg ml-1), chloramphenicol (30 µg ml-1), kanamycin 
(50 µg ml-1), and tetracycline (12.5 µg ml-1).  All E. coli strains were stored at -
80°C in LB broth with 20% glycerol. 
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Table 3.2: Strains and Plasmids used in this study 
 
Strain or 
Plasmid 
Relevant Characteristics Reference 
Bacteria   
E. coli   
DH5α supE44 ΔlacU169 (Ф80lacZΔM15) hsDr17 recA1 
endA1gyrA96 thi-1 relA1 
Lab strain 
GM2163 dam-, dcm-, camR New England 
Biolabs 
DH5 pRK212.1 contains conjugative plasmid for transferring DNA into 
Campylobacter 
[236] 
   
C. jejuni   
81-176 clinical isolate [237] 
11168 Clinical isolate  
DRH153 81-176 astA::aphA3; Kanr [238] 
DRH154 81-176 astA::cat, CmR [238] 
DRH212 81-176 rpsLSm [238] 
JMB200 DRH212 ctsM::kan, KanR This study 
JMB202 DRH212 NAR This study 
JMB204 DRH212 ctsM::cm, CmR This study 
   
Plasmids   
pUC19 AmpR New England 
Biolabs 
pEC0102 pRY112 derivative with cat promoter [5] 
pJMB200 pUC19 ctsM::kan, KanR This study 
pJMB201 pUC19 ctsM::cm, CmR This study 
pJMB202 pUC19astAkan, KanR This study 
pJMB203 pUC19astAcm, CmR This study 
pJMB204 pJMB203 + new EcoRI site at 4053, CmR This study 
pJMB205 pJMB203 only 1 EcoRI site in MCS, CmR This study 
pJMB206 pJMB203 only 1 EcoRI, in astA, CmR This study 
pJMB207 pJMB203 only 1 EcoRI site at 4053 (away from insert), 
CmR 
This study 
pJMB208 pJMB203 no EcoRI sites, CmR This study 
 
3.5.3 Construction of ctsM::kan and ctsM::cm mutants 
To create insertional mutants we used Gibson assembly.  We designed 
primers according to the NEB Assembly Tool.  (All primers used in this study are 
indicated in Table 3.3). We amplified 500bp upstream and downstream of ctsM 
as well as either kanamycin cassette or a chloramphenicol cassette from 
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DRH153 or DRH154 respectively.  These fragments were purified using the 
Qiagen PCR purification kit and quantified using the Qubit 2.0.  We also digested 
pUC19 with BamHI and SalI. The digested plasmid was purified using the Qiagen 
PCR purification kit and quantified using the Qubit 2.0. The PCR fragments and 
the digested plasmid were then mixed in equimolar ratios according the NEB 
Gibson Assembly Master Mix instructions and incubated at 50°C for 60 minutes.  
They were then transformed into NEB 5-alpha Competent E. coli (High 
Efficiency) cells according to the manufacturer’s instructions.  Cells were then 
plated on LB kanamycin or LB chloramphenicol.  All subsequent clones were 
verified by sequence determination.  Plasmids were transformed into C. jejuni 
using electroporation and plated on MH agar with appropriate antibiotics. gDNA 
was purified and the creation of the mutant was confirmed using PCR.  
Table 3.3: Primers used in this study 
Number Name Sequence (5’-3’) Description 
  145 ctsM kan/CM GA 
1 
ATT CGA CGT CGG TAC CCG GGT GTG TTG GCG 
ATG ATG GC 
Used to make ctsM::kan and 
ctsM::cm insertional mutants 
146 ctsM Kan GA 2 TCA TTT TAG CCA TAA TTT AAA ACC TTT AAA AGC 
CTT ATC CAC 
Used to make ctsM::kan insertional 
mutant 
147 ctsM Kan GA 3 GGT TTT AAA TTA TGG CTA AAA TCA CAA TAT 
CAC 
Used to make ctsM::kan insertional 
mutant 
148 ctsM Kan GA 4 AGC ACA AAA TCT AAA ACA ATT CAT CCA GTA 
AAA TAT AAT ATT TTA TTT TTC 
Used to make ctsM::kan insertional 
mutant 
149 ctsM Kan GA 5 ATT GTT TTA GAT TTT GTG CTA AAA TTA TAT TTA 
TAA AAA GG 
Used to make ctsM::kan insertional 
mutant 
150 ctsM Kan/CM 
GA 6 
CAA GCT TGC ATG CCT GCA GGC TTT TAT TGA 
GAC TAA TCT TAC TCA TTT TTA AAA C 
Used to make ctsM::kan and 
ctsM::cm insertional mutants 
151 ctsM CM GA 2 TTA ACT TGG AAA TTT AAA ACC TTT AAA AGC CTT 
ATC CAC 
Used to make ctsM::cm insertional 
mutant 
152 ctsM CM GA 3 GGT TTT AAA TTT CCA AGT TAA TTG CGT GAT ATA 
G 
Used to make ctsM::cm insertional 
mutant 
153 ctsM CM GA 4 AGC ACA AAA TTG CGC CCT TTA CTT CCT AAA G Used to make ctsM::cm insertional 
mutant 
154 ctsM CM GA 5 AAA GGG CGC AAT TTT GTG CTA AAA TTA TAT 
TTA TAA AAA GG 
Used to make ctsM::cm insertional 
mutant 
183 pUC19astA F GGC ACT TTT GGC GGG TTC TAC C Used to create astAkan PCR 
fragment 
184 pUC19astA R GGA TCA TAA TCA ACG CTA TTT ACA TGA GCC C Used to create astAkan PCR 
fragment 
185 M13 F TGT AAA ACG ACG GCC AGT Used to create M13 PCR product 
186 M13 R CAG GAA ACA GCT ATG ACC Used to create M13 PCR product 
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187 astA1 F GA AGT GAA TTC GAG CTC GGT ACC CGG GAT GAG 
ACT TAG CAA AAC TCT TTG 
Used to make pJMB202 and 
pJMB203 
188 astA1 cm R GA CAA TTA ACT TGG AAA CAA CAT TAC CAT TCT CAT 
C 
Used to make pJMB203 
189 CM F GA TGG TAA TGT TTC CAA GTT AAT TGC GTG ATA 
TAG 
Used to make pJMB203 
190 CM R GA ATC TCC AAT CAT CAA TGC GCC CTT TAG TTC C Used to make pJMB203 
191 astA 2 CM F GA TAA AGG GCG CAT TGA TGA TTG GAG ATT GTA 
TGA G 
Used to make pJMB203 
192 astA 2 R GA TAC GCC AAG CTT GCA TGC CTG CAG GTT ATT TTT 
TAG GAT TGA ATG CTT GAT C 
Used to make pJMB202 and 
pJMB203 
193 astA 1 Kan R GA TCA TTT TAG CCA TTC ATT TTA GCC ATA ACA ACA 
TTA C 
Used to make pJMB202 
194 Kan F GA ATG GCT AAA ATG AAT GGC TAA AAT GAG AAT 
ATC AC  
Used to make pJMB202 
195 Kan R GA ATC TCC AAT CAT CCT AAA ACA ATT CAT CCA GTA 
AAA TAT AAT ATT TTA TTT TC 
Used to make pJMB202 
196 astA2 Kan F GA TGA ATT GTT TTA GGA TGA TTG GAG ATT GTA 
TGA G 
Used to make pJMB202 
197 Kan qPCR F 
 
GAA AGC TGC CTG TTC CAA AG 
 
Used for binding and uptake assay 
to amplify off kan fragment 
198 Kan qPCR R 
 
GAA AGA GCC TGA TGC ACT CC 
 
Used for binding and uptake assay 
to amplify off kan fragment 
79 CtsX RT F GCATTTGGAGCAAAAGATTC Used for binding and uptake assay 
to amplify off chromosome 
80 CtsX RT R GTGTATTTTCCTGCACCG Used for binding and uptake assay 
to amplify off chromosome 
199 a1317cF ACG ACG GCC AGT GAC TTC GAG CTC GGT AC Used for SDM to eliminate EcoRI 
site in pUC19 MCS 
201 g1594 CAA ATG GTC AAA CTA TTT CTT ATA ATG TCA ATT 
CTA AAA TGG CTA AGA CTT ATG 
For SDM. Remove 1st EcoRI site in 
astA 
203 a1624c F AAA ATG GCT AAG ACT TAT GGT GGC ATT CCT 
ATT TTT GGA CTT TAT CC 
For SDM. Remove 2nd EcoRI site 
in astA 
205 c4053g F GTG AAA TTG TTA TCC GCT CAG AAT TCC ACA 
CAA CAT ACG AG 
For SDM. Add EcoRI site in 
plasmid backbone. 
207 ctsM GA comp 1 AGC TCG GTA CCC GGG GAT CCA AAG AAA ATC 
CTT CTT TTT TAA AAG AG 
Used to make ctsM 
complementaiton plasmid 
208 ctsM GA comp 2 TTG CAT GCC TGC AGG CTC GAG TTT TTA ATT TTT 
AAC TAA AAT ATA AAG 
Used to make ctsM 
complementaiton plasmid 
 
3.5.3 Construction of pJMB202 and pJMB203 
To create these plasmids, we used Gibson assembly.  We designed 
primers according to the NEB Assembly Tool.  (All primers used in this study are 
indicated in Table 3.3). We amplified the first 975 nucleotides of astA from 81-
176, either the kanamycin or chloramphenicol cassette from DRH153 and 
DRH154 respectively, followed by the remainder of astA. These fragments were 
purified using the Qiagen PCR purification kit and quantified using the Qubit 2.0.  
We also digested pUC19 with BamHI and SalI. The digested plasmid was 
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purified using the Qiagen PCR purification kit and quantified using the Qubit 2.0. 
The PCR fragments and the digested plasmid were then mixed in equimolar 
ratios according the NEB Gibson Assembly Master Mix instructions and 
incubated at 50°C for 60 minutes.  They were then transformed into NEB 5-alpha 
Competent E. coli (High Efficiency) cells according to the manufacturer’s 
instructions.  Cells were then plated on LB kanamycin or LB chloramphenicol.  All 
subsequent clones were verified by sequence determination.  
3.5.4 Construction of pJMB204-209 
To create these plasmids, we used site directed mutagenesis of pJMB203.  
This plasmid has three EcoRI sites.  We used the QuikChange Lightning Site-
Directed Mutagenesis Kit from Agilent and followed the manufacturer’s 
instructions to design primers to either add a new EcoRI site on the plasmid 
backbone, greater than 1 kb from the insert, or to eliminate EcoRI sites so there 
was only one site left on the plasmid. We made single nucleotide changes in all 
cases and the resulting sites are not capable of being recognized by either EcoRI 
or CtsM.  
3.5.5 gDNA purification 
Campylobacter cells were grown on MH agar plates with appropriate 
antibiotics as previously described.  For transformation assays, a small amount 
of cells (1-2 passes with an inoculating loop) was scraped off the plate and 
resuspended in 300µL filter sterilized genomic lysis buffer (50 mM Tris Base pH 
7.5, 50 mM EDTA, 1% SDS, 10 mM NaCl).  The cells were heated at 95°C for 10 
minutes.  150 µL of Epicenter MPC Protein Precipitation Reagent was added and 
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cells were vortexed for twenty seconds.  They were then incubated on ice for five 
minutes and spun at 14,000 rpm for 15 minutes.  After centrifugation, the 
supernatant was transferred to a clean 1.5 ml tube and 750 µL of isopropanol 
was added.  This was mixed by inversion and centrifuged again at 14,000 rpm for 
five minutes.  The pellet was then washed twice with 70% ethanol. After washing, 
all ethanol was removed and the pellet was dried in a SpeedVac for 10 minutes 
and then resuspended in 100 µL of dH2O.  The concentration was determined 
using the Qubit 2.0.  
3.5.6 Transformation assays 
Transformation assays were performed as described previously with minor 
changes [5, 193].  Briefly, C. jejuni was grown 16 – 18 hours on MH agar plates 
supplemented with appropriate antibiotics.  Cells were resuspended in MH broth 
to an optical density at 600 nm of 0.5 and 500 l aliquots were added to 13 mm 
test tubes.  Unless otherwise indicated, one microgram of DNA (genomic, 
plasmid, or PCR product) was added to the tubes and the cultures were 
incubated for four hours at 37°C in 5% CO2. The number of transformants and 
the total number of bacteria were determined by dilution plating on MH agar with 
appropriate antibiotics. Biphasic growth conditions and initial 3h incubation at 
37°C in 5% CO2 were found to not be necessary for transformation (See 
Appendix A). Transformation efficiency represents the number of transformants 
per total number of bacteria per microgram of DNA.  Transformations were 
conducted in triplicate and repeated at least three times.  Transformation 
efficiency represents the average of three experiments.  
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3.5.7 In vitro methylation 
DNA MTases (M. EcoRI, M. HpaII, M. TaqI) were purchased from NEB.  
DNA was then methylated according to instructions using the appropriate buffer 
and SAM.  After incubation, the DNA was purified. Plasmid and PCR fragments 
were purified using the Qiagen PCR purification kit.  Genomic DNA was purified 
using ethanol precipitation.   After purification, the DNA was quantified using the 
Qubit 2.0 and the methylation status was tested using appropriate restriction 
enzyme digestion.  Methylation was deemed complete if the DNA was protected 
from degradation after a one hour digest as determined by gel electrophoresis. 
3.5.8 qPCR Binding and Uptake assays 
C. jejuni was grown for sixteen to eighteen hours on MH agar plates 
supplemented with appropriate antibiotics.  Cells were resuspended in MH broth 
to an optical density at 600 nm of 0.5 and 200 l aliquots were made.  One 
microgram of DNA was added to these cells and they were incubated at 37°C for 
one hour.  The cells were pelleted and resuspended in fresh MHB to remove 
DNA not associated with the cell.  Half the samples were placed on ice and the 
other half had 10 µl DNase added and were incubated an additional thirty 
minutes at 37°C.  All cells were then pelleted and washed again.  DNA was 
prepared as previously described.  DNA was quantified using a Qubit. 20 ng of 
DNA was added to a qPCR reaction.  Primers are indicated in Table 3.3.   
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CHAPTER IV 
 
CONCLUSION AND PERSPECTIVES 
 
4.1 Conclusions 
The goal of my thesis was to investigate to different parts of natural 
transformation in C. jejuni. In Chapter II, I examined the role of three proteins 
involved in the competence machinery, CtsE, CtsP, and CtsX. In Chapter III, I 
examined how C. jejuni selected the DNA it used in transformation.   
 CtsE, CtsP and CtsX were found to be involved in transformation in C. 
jejuni based on a transposon screen. Based on homology, we hypothesized CtsE 
and CtsP were ATPases. We proved that they were NTPases and that their 
NTPase activity was required for transformation by making point mutations that 
disrupted their Walker boxes.  When these point mutants were expressed in C. 
jejuni, the cells were unable to be transformed.  However, we cannot conclusively 
state that they are ATPases as we did not do in vitro assays testing for ATP 
cleavage. In other systems, similar ATPases associate with the membrane in 
order to power the production or retraction of the pilus.  In the membrane 
localization studies I performed, we saw localization to the membrane for both 
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proteins, but the localization had features that were distinct from other systems.  
CtsE primarily localized to the cytosol, though a small percentage was seen at 
the membrane.  We also determined that CtsE oligomerizes. CtsP strongly 
associated with the membrane but it did this without requiring any other individual 
Cts protein. We did see that it interacted with CtsX, which has no overall 
homology to other proteins.  CtsX is a single-pass transmembrane protein 
required for transformation.  We determined that the N terminus of the protein is 
in the cytosol and the C terminus is in the periplasm.  However, we still do not 
know the specific role of this protein in competence. 
 From the first identification of competence in C. jejuni, it has been 
observed that C. jejuni is selective in the DNA that it uses for transformation 
[193].  However, the basis of that selection has been unclear until now.  I 
identified a new DNA uptake sequence, methyl-RAATTY.  This sequence is 
methylated in vivo by the orphan MTase CtsM but can be methylated in vitro by 
M. EcoRI. When DNA is not methylated at this sequence, it fails to transform C. 
jejuni cells.  We determined this was true for both laboratory isolates we tested, 
81-176 and 11168.  However, the presence of CtsM is not required for 
transformation.  In cells lacking CtsM, the same substrate specificity was 
demonstrated. Furthermore, I demonstrated that we could take DNA that has 
never been a transformation substrate, DNA derived from E. coli or from PCR, in 
vitro methylate this site, and convert the DNA into transformation substrate.  I 
also determined that only one methylated RAATTY site was required, and that 
that site could be at least a one kilobase away from the DNA that will ultimately 
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recombine onto the chromosome.  Finally, I determined that DNA lacking 
methylation at RAATTY sites is transported into the cell to the same degree that 
fully methylated DNA is.   
 This work has demonstrated that C. jejuni functions similarly to other 
competence systems in that it has two ATPases that are required for 
transformation and that it encodes a mechanism for selecting the DNA that it 
uses in transformation.  However, when taken as a whole, the C. jejuni 
competence system has many unique characteristics that separate it from other 
competence systems.  As discussed previously, the Cts system is not the sole 
transformation system encoded in the genome.  To our knowledge, no other 
bacterium has been found that contains two separate transformation systems.  
Furthermore, within the Cts system, there are many unique features.  The 
localization of CtsE and CtsP differ from previously studied competence 
ATPases.  At the sequence level, CtsP does not look like other competence 
retraction ATPases and has been placed in unique class of ATPases [183].  CtsX 
has no homology to other proteins but is still required.  We initially hypothesized 
that CtsX might functionally replace a protein found in other systems that the Cts 
system was missing, but we have yet to identify any missing protein in this 
system.  The mechanism of DNA selection is distinct as well.  Other systems use 
uptake sequences, but these are not methylated.  Furthermore in other systems 
with uptake sequences, selection occurs on the outer membrane where the 
receptor protein ComP recognizes the DUS and allows the DNA to enter the cell 
[95].  As DNA lacking RAATTY methylation enters the cells as well as fully 
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methylated DNA, this cannot be the mechanism of selection.  In other cases 
where methylation is important, there is a cognate restriction enzyme to degrade 
DNA lacking the methylation. However, there is no restriction enzyme present to 
perform this function.   
4.2 Perspectives  
My work has answered a number of questions about natural 
transformation in C. jejuni but there are still many questions yet to be answered.  
There are new questions brought to life by my research, both regarding the 
transformation machinery itself and DNA selection.  There are also more general 
questions about the regulation of transformation. 
 In terms of the competence machinery, we still have not addressed the 
individual roles of the two ATPases.  We know that they are each required and 
that their individual ATPase functions are required, but we do not know how or 
when that energy is used by the system. In other systems, these ATPases power 
the production and retraction of a pilus [29, 73, 212].  C. jejuni has not been 
demonstrated to produce a pilus and does not encode the gene for the major 
pilin subunit.  However, pseudopili have been demonstrated to work in 
competence and C. jejuni does encode to pseudopilins [5, 241]. We also do not 
know if CtsE transits to the membrane upon a signal, such as the presence of 
DNA, or if the amount we detect at the membrane is sufficient to power the 
system. We found that CtsP has a strong association with the membrane 
independent of other individual components but we do not know the mechanism 
of that interaction.  It is possible that it can interact with multiple components of 
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the system and that when we removed individual components of the system, 
there were still other interacting partners present to facilitate the interaction.  To 
test this hypothesis, we would need to make strains lacking multiple components 
of the system.  However, when I expressed ctsP in E. coli, it still interacted with 
the membrane. This indicates it might not be a Cts specific mechanism. Finally 
we do not know the role of CtsX.  The primary amino acid sequence does not 
have homology to other proteins.  However, if we use Phyre 2 or programs that 
predict homology based on predicted structure, we do identify an interesting area 
of homology towards the C terminus.  This region, predicted to be in the 
periplasm, looks likes chaperones involved in Type III secretion.  This leads us to 
hypothesize that CtsX might be involved in stabilizing the competence machinery 
or helping periplasmic proteins fold properly.   
 As previously discussed, the uptake sequence we identified is different 
from other uptake sequences.  While I have tested it in two lab strains of C. 
jejuni, we do not know if this mechanism will hold true for all C. jejuni strains, 
particularly environmental isolates, or if it will work for more distantly related 
strains such as C. coli. CtsM is conserved and has been found to be active in 
distantly related strains such as C. subantarticus. Competence has not been 
studied in Campylobacter species other than C. jejuni and C. coli, so we do not 
know if these species are naturally competent and if they are, how selective they 
are in the DNA they use. I also have yet to determine the mechanism of 
selection.  Based on the DNA binding and uptake assays that I performed, the 
DNA lacking RAATTY methylation is transported into the cell similarly to fully 
 114 
 
methylated DNA. This means selection must occur inside the cell. Based on this, 
there are a number of possibilities for the mechanism of selection.  1) There is a 
protein in the periplasm that binds to and recognizes methyl-RAATTY and this 
binding event allows transport of the DNA into the cytosol. 2) All of the DNA is 
transported into the cytosol, independent of methylation state, and then only 
properly methylated DNA recombines onto the chromosome.  3) There is a 
methylation specific restriction enzyme that is always trapped in the periplasm.  
This is the least likely of the three hypotheses because ctsM insertional mutants 
do not appear to have any growth defects.  If such a restriction enzyme exists, it 
would target the chromosomal DNA in these cells anytime it erroneously 
remained in the cytoplasm and would kill the cell.  To determine the mechanism 
of specificity, I have attempted to purify perplasmic fractions and to test if there is 
an enrichment of DNA lacking RAATTY methylation in this fraction.  This would 
indicate the DNA is trapped in the periplasm and would point to the first 
hypothesis.  A pulldown assay looking for proteins that specifically bind RAATTY 
methylated DNA could also help address this question. Finally, orphan MTases 
have been implicated in gene regulation in other systems.  As this MTase is 
highly conserved among Campylobacter species, it is likely that it plays a role in 
more than transformation. There are conspicuous regions of either 
hypomethylation or the lack of possible methylation motifs. These include 16S 
and 23S ribosomal RNAs, flagellar proteins including FlgK and  a flagellar basal-
body rod protein, FtsZ, and central metabolism proteins including SucC and 
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SucD [153]. This indicates that CtsM might be involved in peigentic regulation 
similar to CcrM and Dam.  This could be assessed by RNAseq.  
 There are also a number of outstanding questions about transformation in 
C. jejuni that my research did not touch upon. We still do not know the function of 
the Vir transformation system.  It is likely that it is important in some yet to be 
determined environmental condition, though why the Cts system would not be 
sufficient is not clear.  The regulation of competence is not clear.  It seems like 
the Cts system is constitutively active, but there are environmental conditions 
where the system is more active—higher temperatures, microaerophilic 
conditions [1, 2].  Furthermore, translation inhibitors eliminate transformation [1]. 
All of these indicate that there is some regulation that happens and that it is likely 
post-transcriptional.  RNA-seq data from our lab indicate that different 
environmental conditions such as chicken colonization, mid-log growth or 
exponential growth,  do not significantly impact transcription of the Cts operon 
[242]. We also do not know if all cells are competent such as in S. pneumoniae 
or if only a subset of cells are actively competent such as in B. subtilis.  In 
species such as V. cholerae, an environmental signal is needed to induce 
competence.  While C. jejuni seems to be constitutively active, the number of 
transformants produced is lower than in other species.  Therefore, there might be 
an environmental signal that upregulates the system to increase overall 
transformation efficiency.   
 The work presented in this thesis addressed some mechanistic questions 
regarding DNA selection and the roles of individual Cts proteins in C. jejuni 
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transformation.  However, there are many outstanding questions that remain to 
be answered.   
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APPENDIX A 
EVALUATION OF BIPHASIC TRANFORMATION PROTOCOL 
 The published protocol for C. jejuni natural transformation is time 
intensive.  Cells, grown overnight on plates, are resuspended to an OD of 0.5.  
0.5 ml of that culture is added to a biphasic tube (a tube with 1 ml MH agar in the 
bottom) and allowed to incubate for three hours at 37°C and 5% CO2 and then 1 
µg of DNA is added.  After the addition of DNA, the cells are returned to the 
previous conditions and incubated for an additional four hours and then dilutions 
are plated on antibiotic containing media to measure transformants.  However, 
there was no indication why this protocol was used and what the effects on 
transformation efficiency were if these parameters were changed.  Therefore, I 
wanted to test three different parts of this protocol for their effect on 
transformation efficiency.  First I tested the role of the biphasic tubes. Second, I 
tested the role of the pre-DNA incubation period.  Third, I tested the role of the 
post-DNA incubation period.   
 As the logic behind all of these steps is not included in any of the 
publications that used this protocol, I can only speculate to the reason behind 
them. Biphasic growth is often used when cell density affects the phenotype 
being tested, such as production of lantibiotics in S. pneumoniae [243]. However, 
the cultures are not stabbed into the agar nor are the mixed into warm agar.  It is 
possible that aggregation could occur when the cells fall out of suspension which 
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happens because the tubes are not shaking in the incubator.  Cell density does 
affect competence in other systems so it is possible this was a way to account for 
that.  However, we now know that C. jejuni is constitutively competent, so this 
would have no effect.  When I kept the rest of the transformation protocol the 
same but performed the protocol in regular tubes as opposed to biphasic tubes, I 
saw no difference in transformation efficiency (Fig A1).  Based on this data, I 
eliminated this step.  
 
Figure A1. Biphasic tubes do not affect transformation efficiency. WT C. jejuni was 
transformed with kanr gDNA in either biphasic tubes (broth + agar) or in regular tubes 
(broth only).  Transformation efficiency was calculated as before.  This was done in 
triplicate.  Student’s t test was done to compare the two samples and no difference was 
determined.  
  
I then tested the role of the pre-DNA incubation phase.  I took identical 
cultures and incubated them at 37°C and 5% CO2 for between thirty minutes and 
3 hours. I then added DNA and allowed the cells and DNA to incubate for an 
additional four hours before I plated for transformants.  Again, I can only 
speculate as to why this step was included.  In some bacteria, competence is 
triggered by stress and C. jejuni does prefer higher CO2 conditions [37].  Perhaps 
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the idea was to stress the bacteria by placing them in a low carbon dioxide 
environment which would then induce them to upregulate competence genes.  
When I performed this experiment, I saw no difference between the cells that I 
preincubated at 37°C and 5% CO2 and those that I did not (Fig A.2).  Therefore I 
eliminated this step as well.  
 
Figure A2. Preincubation in low CO2 does not affect transformation efficiency. WT 
C. jejuni cells were transformed with kanr gDNA.  Before the addition of gDNA, the 
placed in biphasic tubes and incubated for various lengths of time at 5% CO2 and 37°C.  
After the addition of 1 ug of DNA, the cells were further incubated for 4 hours in the 
previous conditions. Transformation efficiency was calculated as before. This was done 
in triplicate. One way ANOVA with Dunnett’s multiple comparison test were performed 
and no statistical difference was determined for any of the samples. 
  
Finally, I tested the role of the post DNA incubation phase.  Again, no 
reasoning was included for the length of this period but most transformation 
protocols do include an incubation period after adding DNA.  It does take some 
time for the bacteria to bind to the DNA, transport it through both membranes, 
and then recombine it onto the chromosome.  As we measure transformation by 
the number of bacteria that become resistant to the antibiotic cassette provided, 
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increasing this time should allow for more transformants.  When I varied the post-
incubation period from 30 minutes to the normal 4 hours, I saw an increase in 
transformants as I increased the incubation time (Fig A3).   
 
Figure A3. Incubation time in the presence of DNA affects transformation 
efficiency. WT C. jejuni was transformed with kanr gDNA.  Cells were preincubated at 
5% CO2 and 37°C for three hours before the addition of 1ug of gDNA.  Cells were then 
incubated at the previous conditions for various lengths of time before being plated to 
determine transformants.  Dotted line indicates limit of detection. Transformation 
efficiency was calculated as before.  One way ANOVA and Dunnett’s multiple 
comparison test was performed and all samples were compared to the 4-hour incubation 
time point.  All of the time points were significantly lower than the 4-hour time point.  
 
Based on these experiments, I modified the transformation assay such 
that I grew the cells overnight on plates, made a 0.5 OD suspension.  I aliquoted 
0.5 ml of that suspension to tubes and then added 1 µg of DNA to the cells and 
allowed them to incubate at 37°C and 5% CO2 for four hours and then I made 
serial dilutions and plated for transformants.  When I directly compared this 
method to the original protocol, in every case but one I saw no difference 
between the original protocol and the new protocol.  When I did see a difference 
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(WT), there was a higher transformation efficiency with the new protocol (Fig A4).  
 
Figure A4. The modified transformation protocol works as well or better than the 
original protocol. Different strains of C. jejuni were transformed with kanr gDNA using 
either the original transformation protocol as previously described or a new protocol in 
which I skipped the pre-DNA incubation step and did not use biphasic tubes.  
Transformants were calculated as previously described. This experiment was done in 
triplicate.  Data was analyzed by two-way ANOVA with Tukey’s multiple comparison 
tests.  The only statistical difference was between the WT strains with a p-value of 0.02.  
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APPENDIX B 
NATURAL TRANSFORMATION OF ENVIRONMENTAL STRAINS OF 
CAMPYLOBACTER 
 
The majority of the work that I did over the course of my thesis involved 
the laboratory strain 81-176 or its streptomycin resistant derivative DRH212.  
This is one of the best characterized C. jejuni strains. It was originally isolated 
from a patient who became ill with campylobacteriosis after drinking raw milk in 
1989 [237].  We were curious about how naturally competent recent 
environmental isolates were, especially in comparison to 81-176.  A post-doctoral 
fellow in the lab, Michael Taveirne, was performing a farm study looking at the 
prevalence of Campylobacter in pasture raised chickens and comparing the 
microbiota of those chickens with the chickens we raise in the animal facility for 
our colonization studies.  In the course of this study as well as another study in 
collaboration with the University of Michigan Hospital looking at recent human 
isolates of Campylobacter, he isolated a number of chicken and human isolates.  
I took some of those strains and tested if they were competent.   
 We initially started with two chicken isolates, MTVDSCJ20 and SCC1.  
MTVDSCJ20 is a C. jejuni strain that we eventually did whole genome 
sequencing on.  SCC1 is C. coli strain.  These were both isolated from pasture-
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raised chickens.  I first tested their ability to be transformed by DNA derived from 
DRH212, containing either a kanamycin cassette or a point mutation conferring 
naladixic acid (NA) resistance (Fig B1).  Neither of these strains were competent 
based on this experiment.  There were a few colonies detected when we used 
NAr  gDNA.  However, this is most likely because this resistance is conferred by a 
point mutation and we always recover spontaneous mutants naladixic acid 
containing plates (data not shown). As we suspected that methylation played an 
important role in DNA selection in transformation, this was not completely 
surprising. We did not have genome sequences for either of these strains at this 
point, but all of the sequenced strains contained the Cts system, so we 
speculated that the transformation defect was due to a difference in methylation 
between 81-176 and these two environmental strains. 
 
Figure B1. Environmental isolates of Campylobacter are not transformed 
with gDNA from 81-176. Different strains of Campylobacter were transformed 
with either kanr gDNA from 81-176 (yellow) or naladixic acid resistant gDNA from 
81-176 (blue). Transformation efficiencies were calculated as before.  The 
experiment was done in triplicate. N.D. means not detected. The dotted line 
indicates the limit of detection.  
  
If methylation status were affecting transformation in these strains, we 
hypothesized that these strains would be transformable with their own gDNA. In 
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order to do this, we first had to introduce antibiotic cassettes to these strains in 
order to measure transformation.  We introduced a kanamycin resistance 
cassette into MTVDSCJ20.  We also grew both strains on naladixic acid plates 
and isolated spontaneous mutants. I then purified gDNA from all of these strains.  
I then asked if these environmental strains would transform better with their own 
DNA.  I also tested if the DNA from these isolates could transform 81-176 as well 
as a laboratory strain of C. coli. When I did this experiment, I saw the 
environmental isolates were never transformed (Fig B2). I did recover colonies 
when I grew the colonies on naladixic acid containing plates, but no more than 
my no DNA control (green and purple vs blue bars).  I never saw transformants 
using the kanamycin resistant gDNA from MTVDSCJ20.  This supported our 
hypothesis that methylation plays a role in transformation because DNA from 
MTVDSCJ20 could not transform 81-176, which we know transforms well. 
 
Figure B2. Environmental strains are not transformed with their own DNA. 
Four strains of Campylobacter were transformed with DNA as indicated. 
Transformation efficiency was measured as before.  The blue bars indicates the 
cells were treated identically to cells that were transformed but no DNA was 
added and then the cells were plated on naladixic acid containing media in order 
to determine the rate of spontaneous mutation. The dotted line indicates the limit 
of detection and nd indicates no colonies were determined. No DNA controls 
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were also done for kanamycin resistant but no colonies were detected for any 
strain so that data is not plotted.  
  
While the previous experiment indicated there might be differences in the 
methylation status of the DNA between 81-176 and MTVDSCJ20 because kanr 
gDNA derived from MTVDSCJ20 was incapable of transforming 81-176, it did not 
explain the lack of transformation with their own DNA that we saw for either 
environmental strain.  We then tested these strains, as well as other non-
laboratory isolates, for their ability to produce eDNases. Campylobacter is 
capable of producing up to three eDNases and all are capable of inhibiting 
transformation [49, 50].  We therefore grew the cells overnight, normalized the 
ODs, spun them down and filtered the supernatants to remove any remaining 
bacteria. We then treated 81-176 gDNA with these supernatants and looked for 
the degradation of DNA (Fig B3).  Overall, we saw three distinct phenotypes. In 
some cases such as our laboratory strain 81-176, there was no degradation, 
indicating lack of eDNase activity.  We also saw complete degradation of the 
gDNA, indicating strong eDNase activity.  This was the case for both previously 
tested environmental strains—MTVDSCJ20 and SCC1. Finally, we saw one 
case, H15, where there was some activity, indicated by smearing of the gDNA, 
but it was not as strong as in the other cases of activity that we saw.  This data 
explained our transformation phenotypes—the eDNases produced by 
MTVDSCJ20 and SCC1 were eliminating any possible transformation that was 
occurring by degrading any extracellular DNA.  We eventually did full genome 
sequencing on MTVDSCJ20. Based on these data, we determined that it has a 
fully intact Cts system and that it encodes one of the identified eDNases.  This 
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indicates, as has previously been reported, that a single eDNase is sufficient to 
eliminate natural transformation [49, 50]. 
 
Figure B3. eDNase activity of non-laboratory isolates.  A panel of non-
laboratory strains were tested for their eDNase activity. gDNA was added to 
supernatants, incubated for an hour, and then run on an agarose gel.   
  
Based on this experiment, we did identify other environmental isolates, 
SCJ7 and SCJ13 that did not have eDNase activity as well as H15, which had 
weak eDNase activity. We then examined transformation in these strains. We 
first tested these strains with 81-176 gDNA.  We found for SCJ7 and SCJ13, the 
strains that had no eDNase activity were capable of being transformed, though 
they transformed less efficiently than 81-176. However, the strain that had a 
small amount of eDNase activity was not transformed (Fig B4).    
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Figure B4. Environmental strains lacking eDNase activity can be 
transformed by 81-176 gDNA. Various Campylobacter strains were transformed 
with 81-176 kanr gDNA and transformation efficiency was calculated as 
previously described. These strains are color coded based on if we detected 
eDNase activity in the assay described in Fig B3. Blue indicates no eDNase 
activity and yellow indicates some activity.  This is also designated in parenthesis 
next to the strain name by a plus or a minus.  +/- indicates weak activity was 
detected. The dotted line indicates the limit of detection.  
  
While we saw no transformants for H17, we could not conclude if this was 
because of the presence of eDNases or because there was some methylation-
dependent difference between its DNA and the DNA from 81-176. Therefore, I 
grew these strains on naladixic acid containing media in order to elicit 
spontaneous naladixic acid point mutants.  I then purified the NAr gDNA from 
these strains and tested the ability of this DNA to transform the environmental 
strains as well as 81-176 (Fig B5). 
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Figure B5. Environmental isolates can be transformed with their own 
gDNA. Various Campylobacter strains were transformed with the various type of 
DNA indicated. Transformation efficiency was calculated as previously described.  
I did not transform all environmental strains with all possible types of DNA.  This 
is indicated by a nd where I did not determine transformation efficiency.  The 
dotted line indicates the limit of detection. Where no colonies were detected, bars 
were set to the limit of detection.  
 
Both of the strains lacking eDNase activity were able to be transformed 
with their own DNA. While colonies were detected for H17, the strain with weak 
eDNase activity, there were only slightly more colonies than in the no DNA 
control.  This most likely indicates that the eDNase is strong enough to degrade 
the added DNA and that the colonies we are detecting are spontaneous mutants.  
Interestingly, neither SCJ7 nor SCJ13 were more transformable with their own 
gDNA.  They were still less transformable than 81-176. Furthermore, their gDNA 
did not transform 81-176 as well as its own gDNA. 
These experiments were all performed before I identified the DNA 
selection mechanism in C. jejuni. We do not have genome sequences for these 
isolates.  However, I would hypothesize that SCJ7 and SCJ13 both have ctsM as 
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without CtsM methylation, I do not see any transformants in 81-176.  Therefore, 
the gDNA from these strains must have RAATTY methylation.  This does not 
explain the difference we see in the transformation efficiencies I see when using 
gDNA from these strains. It is likely that the genomes for these strains differ from 
81-176.  As mentioned previously, C. jejuni is known to have a great deal of 
genetic diversity.  Therefore, it is possible that the DNA flanking the point mutant 
is not entirely homologous.  While the exact requirements for transformation have 
not been determined in C. jejuni, decreasing the amount of homologous DNA 
significantly decreases the transformation efficiency in V. cholerae and S. 
pneumoniae [244].  This might explain the difference I observe using different 
DNA.  
This work demonstrates that some environmental strains are naturally 
competent.  However, many more strains of our isolates expressed eDNases 
than did not.  As this expression correlated with the lack of transformation, this 
might indicate that transformation might not be favored in either the chicken or 
the human intestine.  However, this is a very small number of strains to base 
such a conclusion on.  This should be investigated with many more 
environmental isolates.  Furthermore, transformation was less efficient in the 
environmental strains that did not have eDNase activity than in our laboratory 
strain, even when they were transformed by their own DNA.  This indicates there 
is more to transformation and possibly DNA selection in environmental strains 
than in our laboratory strain.  
 
.  
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